Loading
Assoc. Prof. Dr. Watcharin Loilome

Assoc. Prof. Dr. Watcharin Loilome

Department of Biochemistry,
Faculty of Medicine,
Khon Kaen University
13607508400: H-INDEX 35
57195978032: H-INDEX 35

Documents

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Expression and Function of Candidate Genes Involved in Cholangiocarcinama Watcharin Loilome
Puangrat Yongvanit
2005
2. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model W Loilome
P Yongvanit
C Wongkham
N Tepsiri
B Sripa
P Sithithaworn
S Hanai
M Miwa
2006
3. Altered gene expression levels associating with 5-fluorouracil resistance in cholangiocarcinoma cell lines Nisana N. Tepsiri
Watcharin Loilome
Piyawan Amimanan
Patcharee Jearanaikoon
Wichittra Tassaneeyakul
2006
4. Plasma 8-isoprostane: a new biomarker in opisthorchiasis-associated cholangiocarcinoma Puangrat Yongvanit
Somkid Dechakhamphu
Somchai Pinlaor
Nisana N. Tepsiri
Watcharin Loilome
Narong Khantekaew
Paiboon Sithithaworn
2006
5. Prkar1a gene overexpression in liver tissue with cholangiocarcinoma Watcharin Loilome
Anucha Puapairoj
Nisana N. Tepsiri
Paiboon Sithithaworn
Masanao Miwa
Puangrat Yongvanit
2006
6. Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines Nisana Namwat
Banchob Sripa
Watcharin Loilome
Vajarabhongsa Bhudisawadi
Wichittra Tassaneeyakul
2007
7. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines Namwat, N
Amimanan, P
Loilome, W
Jearanaikoon, P
Sripa, B
Bhudhisawasdi, V
Tassaneeyakul, W
2008
8. Over-expression of PRKAR1A in hepatic progenitor cells during cholangiocarcinogenesis induced by liver fluke (Opisthorchis, viverrini) P. Yonavanit
N. Namwat
W. Loilome
R. Thanan
E. Phanomsri
C. Pairojkul
2008
9. Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling Watcharin Loilome
Avadhut D. Joshi
Colette M. J. ap Rhys
Sara Piccirillo
Vescovi L. Angelo
Gary L. Gallia
Gregory J. Riggins
2009
10. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. Hahnvajanawong, C.
Boonyanugomol, W.
Nasomyon, T.
Loilome, W.
Namwat, N.
Anantachoke, N.
Tassaneeyakul, W.
Sripa, B.
Namwat, W.
Reutrakul, V.
2010
11. Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation Hasaya Dokduang
Nisana Namwat
Apinya Jusakul
Vajarabhongsa Bhudisawadi
Watcharin Loilome
Puangrat Yongvanit
Banchob Sripa
Wichittra Tassaneeyakul
2010
12. Erratum: Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling (Journal of Neuro-Oncology DOI:10.1007/s11060- 009-9885-5) Loilome, W. 2010
13. Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling (vol 94, pg 359, 2009) Watcharin Loilome
Avadhut D. Joshi
Colette M. J. ap Rhys
Sara Piccirillo
Angelo L. Vescovi
Gary L. Gallia
Gregory J. Riggins
2010
14. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Eri Takahashi
Eiji Sugihara
Anucha Puapairoj
Masanao Miwa
Hideyuki Saya
Puangrat Yongvanit
2010
15. Adverse Effects Caused by Adaptive Imbalance to Genotoxic Stress after Infection and Inflammation Sasithorn Kadsanit
Chadamas Pinitsoontorn
Watcharin Loilome
Puangrat Yongvanit
2011
16. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases Namwat, N.
Puetkasichonpasutha, J.
Loilome, W.
Yongvanit, P.
Techasen, A.
Puapairoj, A.
Sripa, B.
Tassaneeyakul, W.
Khuntikeo, N.
Wongkham, S.
2011
17. Mechanisms of oxysterol-induced carcinogenesis. Jusakul, A.
Yongvanit, P.
Loilome, W.
Namwat, N.
2011
18. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma Watcharin Loilome
Sirinun Juntana
Nisana Namwat
Vajarabhongsa Bhudhisawasdi
Anucha Puapairoj
Banchob Sripa
Masanao Miwa
Hideyuki Saya
Gregory J. Riggins
Puangrat Yongvanit
2011
19. Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines. Jongthawin, J.
Techasen, A.
Loilome, W.
Yongvanit, P.
Namwat, N.
2012
20. Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasis Wonkchalee, O
Boonmars, T
Aromdee, C
Laummaunwai, P
Khunkitti, W
Vaeteewoottacharn, K
Sriraj, P
Aukkanimart, R
Loilome, W
Chamgramol, Y
Pairojkul, C
Wu, Z
Juasook, A
Sudsarn, P
2012
21. Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis Juasook, A
Boonmars, T
Kaewkes, S
Loilome, W
Veteewuthacharn, K
Wu, Z
Yongvanit, P
2012
22. Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Hasaya Dokduang
Jurairat Jongthawin
Puangrat Yongvanit
2012
23. Down-Regulated Expression of HSP70 in Correlation with Clinicopathology of Cholangiocarcinoma Boonjaraspinyo, S.
Boonmars, T.
Kaewkes, S.
Laummaunwai, P.
Pinlaor, S.
Loilome, W.
Yongvanit, P.
Puapairoj, A.
Bhudhisawasdi, V.
2012
24. Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy. Avadhut D. Joshi
Watcharin Loilome
I-Mei Siu
Betty Tyler
Gary L. Gallia
Gregory J. Riggins
2012
25. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis Loilome, W
Wechagama, P
Namwat, N
Jusakul, A
Sripa, B
Miwa, M
Kuver, R
Yongvanit, P
2012
26. Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of opisthorchiasis-associated cholangiocarcinoma. N. Namwat
P. Chusorn
W. Loilome
A. Techasen
J. Puetkasichonpasutha
C. Pairojkul
N. Khuntikeo
P. Yongvanit
2012
27. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma Yongvanit, P
Phanomsri, E
Namwat, N
Kampan, J
Tassaneeyakul, W
Loilome, W
Puapairoj, A
Khuntikeo, N
2012
28. Identification of Biliary Bile Acids in Patients with Benign Biliary Diseases, Hepatocellular Carcinoma and Cholangiocarcinoma Jusakul, A.
Khuntikeo, N.
Ioannou, G.N.
Loilome, W.
Namwat, N.
Bhudhisawasdi, V.
Pugkhem, A.
Pairojkul, C.
Yongvanit, P.
2012
29. Identification of pathogenic cholesterol oxidation products in hepatic tissue and bile of cholangiocarcinoma patients A. Jusakul
W. G. Haigh
C. Savard
W. Loilome
N. Namwat
N. Khuntikeo
C. Pairojkul
S. Pinlaor
R. Kuver
P. Yongvanit
2012
30. Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development Watcharin Loilome
Sasithorn Kadsanit
Nisana Namwat
Anchalee Techasen
Anucha Puapairoj
Ananya Dechakhamphu
Chadamas Pinitsoontorn
Puangrat Yongvanit
2012
31. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen. Yongvanit, P.
Thanan, R.
Pinlaor, S.
Sithithaworn, P.
Loilome, W.
Namwat, N.
Techasen, A.
Dechakhamphu, S.
2012
32. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. Jusakul, A.
Loilome, W.
Namwat, N.
Dechakhamphu, S.
Sukontawarin, P.
Pinlaor, S.
Lee, S.P.
Yongvanit, P.
2012
33. Molecular Carcinogenesis of Cholangiocarcinoma II: Associated Genes in the Genesis of Cholangiocarcinoma Nisana Namwat
Watcharin Loilome
Puangrat Yongvanit
Thailand Khon Kaen University
2012
34. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis Techasen, A
Loilome, W
Namwat, N
Duenngai, K
Cha'on, U
Thanan, R
Sithithaworn, P
Miwa, M
Yongvanit, P
2012
35. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. Sirintip Boonjaraspinyo
Zhiliang Wu
Thidarut Boonmars
Sasithorn Kaewkes
Watchalin Loilome
Paiboon Sithithaworn
Isao Nagano
Yuzo Takahashi
Puangrat Yongvanit
Vajarabhongsa Bhudhisawasdi
2012
36. PI3K/Akt Signaling Pathway in Normal and Malignant Cells Supak Yothaisong
Watcharin Loilome
2012
37. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma Boonjaraspinyo, S.
Boonmars, T.
Loilome, W.
Sithithaworn, P.
Pinlaor, S.
Yongvanit, P.
Nielsen, P.S.
Pairojkul, C.
Khuntikeo, N.
2012
38. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. Watcharin Loilome
Sasithorn Yooyuen
Nisana Namwat
Paiboon Sithithaworn
Anucha Puapairoj
Junko Kano
Masayuki Noguchi
Masanao Miwa
Puangrat Yongvanit
2012
39. Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells. Loilome, W.
Juntana, S.
Pinitsoontorn, C.
Namwat, N.
Tassaneeyakul, W.
Yongvanit, P.
2012
40. Tumor Microenvironment and its Functions Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
2012
41. Tumor necrosis factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma Techasen, A.
Namwat, N.
Loilome, W.
Bungkanjana, P.
Khuntikeo, N.
Puapairoj, A.
Jearanaikoon, P.
Saya, H.
Yongvanit, P.
2012
42. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol- resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma Jusakul, A
Loilome, W
Namwat, N
Techasen, A
Kuver, R
Ioannou, GN
Savard, C
Haigh, WG
Yongvanit, P
2013
43. Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine. Amornrat Juasook
Thidarut Boonmars
Zhiliang Wu
Watcharin Loilome
Kulathida Veteewuthacharn
Nissana Namwat
Pakkayanee Sudsarn
Orasa Wonkchalee
Pranee Sriraj
Ratchadawan Aukkanimart
2013
44. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy Supak Yothaisong
Hasaya Dokduang
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Vajarabhongsa Bhudhisawasdi
Anucha Puapairoj
Gregory J. Riggins
Watcharin Loilome
2013
45. Inhibitory Effects of Xanthohumol on STAT3 Activation and Cancer Development in Cholangiocarcinoma Xenograft Model Hasaya Dokduang
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Chawalit Pairojkul
Narong Khuntikeo
Yoshinori Murakami
Puangrat Yongvanit
2013
46. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis Chusorn, P
Namwat, N
Loilome, W
Techasen, A
Pairojkul, C
Khuntikeo, N
Dechakhamphu, A
Talabnin, C
Chan-On, W
Ong, CK
Teh, BT
Yongvanit, P
2013
47. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma Jamnongkan, W
Techasen, A
Thanan, R
Duenngai, K
Sithithaworn, P
Mairiang, E
Loilome, W
Namwat, N
Pairojkul, C
Yongvanit, P
2013
48. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment Dokduang, H
Juntana, S
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Riggins, GJ
Loilome, W
2013
49. The expression of PGE2 biosynthesis-related enzymes and PGE2 receptors in cholangiocarcinoma Jurairat Jongthawin
Anchalee Techasen
Puangrat Yongvanit
Watcharin Loilome
Chavalit Pairojkul
Narong Khuntikeo
Nisana Namwat
2013
50. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. Watcharin Loilome
Pornpan Bungkanjana
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Anucha Puapairoj
Narong Khuntikeo
Gregory J. Riggins
2014
51. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. Chakkaphan Khenjanta
Raynoo Thanan
Apinya Jusakul
Anchalee Techasen
Wassana Jamnongkan
Nisana Namwat
Watcharin Loilome
Chawalit Pairojkul
Puangrat Yongvanit
2014
52. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma. Duangkumpha, K.
Techasen, A.
Loilome, W.
Namwat, N.
Thanan, R.
Khuntikeo, N.
Yongvanit, P.
2014
53. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator. Runglawan Silakit
Watcharin Loilome
Puangrat Yongvanit
Porncheera Chusorn
Anchalee Techasen
Thidarut Boonmars
Narong Khuntikeo
Nittaya Chamadol
Chawalit Pairojkul
Nisana Namwat
2014
54. Expression of 14-3-3 Sigma Protein in Cholangiocarcinoma Progression Yingpinyapat Kittirat
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014
55. Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma Xurui Dai
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014
56. Gene Silencing of Translationally Controlled Tumor Protein (TCTP) Nattaporn Phanthaphol
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014
57. Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. Miwa, M
Honjo, S
You, G
Tanaka, M
Uchida, K
Srivatanakul, P
Khuhaprema, T
Loilome, W
Techasen, A
Wongkham, C
Limpaiboon, T
Yongvanit, P
Wongkham, S
2014
58. High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis Suyanee Thongchot
Puangrat Yongvanit
Watcharin Loilome
Wanchana Seubwai
Kutcharin Phunicom
Wichittra Tassaneeyakul
Chawalit Pairojkul
Wisuttiphong Promkotra
Anchalee Techasen
Nisana Namwat
2014
59. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients Chamadol, N.
Pairojkul, C.
Khuntikeo, N.
Laopaiboon, V.
Loilome, W.
Sithithaworn, P.
Yongvanit, P.
2014
60. Increased EphB2 expression predicts cholangiocarcinoma metastasis Khansaard, W.
Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Puapairoj, A.
Loilome, W.
2014
61. Inhibitory effect of xanthohumol on STAT3 activation and cholangiocarcinoma development H. Dokduang
W. Loilome
N. Namwat
C. Pairojkul
M. Sakurai-Yageta
Y. Murakami
P. Yongvanit
2014
62. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anucha Puapairoj
Patcharee Jearanaikoon
Hideyuki Saya
Puangrat Yongvanit
2014
63. Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma. Boonmars, T.
Loilome, W.
Yongvanit, P.
Khuntikeo, N.
Nielsen, P.S.
2014
64. Opisthorchis viverrini Infection Activates the PI3K/AKT/PTEN and Wnt/beta-catenin Signaling Pathways in a Cholangiocarcinogenesis Model Yothaisong, S.
Thanee, M.
Namwat, N.
Yongvanit, P.
Boonmars, T.
Puapairoj, A.
Loilome, W.
2014
65. PGE(2) signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jongthawin, J
Chusorn, P
Techasen, A
Loilome, W
Boonmars, T
Thanan, R
Puapairoj, A
Khuntikeo, N
Tassaneeyakul, W
Yongvanit, P
Namwat, N
2014
66. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma Yongvanit, P.
Pinlaor, S.
Loilome, W.
2014
67. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression Dokduang, H.
Techasen, A.
Namwat, N.
Khuntikeo, N.
Pairojkul, C.
Murakami, Y.
Loilome, W.
Yongvanit, P.
2014
68. Survey of activated kinase proteins reveals PI3K/Akt and Wnt/beta-catenin signaling pathways as potential targets for cholangiocarcinoma treatment W. Loilome
H. Dokduang
S. Yothaisong
P. Bungkanjana
S. Juntana
A. Techasen
N. Namwat
P. Yongvanit
N. Khuntikeo
A. Puapairoj
2014
69. TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma P. Chusorn
N. Namwat
W. Loilome
A. Techasen
C. Pairojkul
N. Khuntikeo
B. Tean Teh
I. Lee
P. Yongvanit
2014
70. Tumor necrosis factor-alpha modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression Techasen, A
Namwat, N
Loilome, W
Duangkumpha, K
Puapairoj, A
Saya, H
Yongvanit, P
2014
71. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. Chanika Worasith
Christine Kamamia
Anna Yakovleva
Kunyarat Duenngai
Chompunoot Wangboon
Jiraporn Sithithaworn
Nattaya Watwiengkam
Nisana Namwat
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Alex Loukas
Paiboon Sithithaworn
Jeffrey M. Bethony
2015
72. A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma. Boonjaraspinyo, S.
Juasook, A.
Boonmars, T.
Aukkanimart, R.
Silsirivanit, A.
Loilome, W.
Sriraj, P.
2015
73. Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells. Thongchot, S.
Loilome, W.
Yongvanit, P.
Dokduang, H.
Thanan, R.
Techasen, A.
Namwat, N.
2015
74. Cohort profile: Cholangiocarcinoma screening and care program (CASCAP) ,
Khuntikeo, N
Chamadol, N
Yongvanit, P
Loilome, W
Namwat, N
Sithithaworn, P
Andrews, RH
Petney, TN
Promthet, S
Thinkhamrop, K
Tawarungruang, C
Thinkhamrop, B
,
,
,
,
,
,
,
,
,
2015
75. Oxidative stress induced LAT1/CD98 expression via PI3K/AKT signaling pathway in cholangiocarcinoma: a potential therapeutic target Supak Yothaisong
Watcharin Loilome
Promsuk Jutabha
Hasaya Dokduang
Hitoshi Endou
Naohiko Anzai
2015
76. Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. Thanee, M.
Loilome, W.
Techasen, A.
Namwat, N.
Boonmars, T.
Pairojkul, C.
Yongvanit, P.
2015
77. A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand. Narong Khuntikeo
Watcharin Loilome
Bandit Thinkhamrop
Nittaya Chamadol
Puangrat Yongvanit
2016
78. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Eiji Sugihara
Shogo Okazaki
Shinya Abe
Shiho Ueda
Takashi Masuko
Nisana Namwat
Narong Khuntikeo
Attapol Titapun
Chawalit Pairojkul
Hideyuki Saya
Puangrat Yongvanit
2016
79. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma Sudsarn, P
Boonmars, T
Ruangjirachuporn, W
Namwat, N
Loilome, W
Sriraj, P
Aukkanimart, R
Nadchanan, W
Jiraporn, S
2016
80. Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma Dai, X
Thongchot, S
Dokduang, H
Loilome, W
Khuntikeo, N
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Techasen, A
Namwat, N
2016
81. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. Hasaya Dokduang
Puangrat Yongvanit
Nisana Namwat
Chawalit Pairojkul
Sakkarn Sangkhamanon
Mika Sakurai Yageta
Yoshinori Murakami
Watcharin Loilome
2016
82. Carcinogenic liver fluke and others contaminated in pickled fish of northeastern Thailand Aukkanimart, R
Boonmars, T
Sriraj, P
Sripan, P
Songsri, J
Ratanasuwan, P
Laummaunwai, P
Suwanantrai, A
Aunpromma, S
Khueangchaingkhwang, S
Pumhirunroj, B
Artchayasawat, A
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
Boonjaraspinyo, S
2017
83. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand Senggunprai, L.
Namwat, N.
Kongpetch, S.
Chamgramol, Y.
Loilome, W.
Khansaard, W.
Jusakul, A.
Prawan, A.
Pairojkul, C.
Yongvanit, P.
Kukongviriyapan, V.
2017
84. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma Watcharin Loilome
Sasithorn Kadsanit
Kanha Muisook
Puangrat Yongvanit
Nisana Namwat
Anchalee Techasen
Anucha Puapairoj
Narong Khuntikeo
Pichai Phonjit
2017
85. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance Yothaisong, S
Namwat, N
Yongvanit, P
Khuntikeo, N
Puapairoj, A
Jutabha, P
Anzai, N
Tassaneeyakul, W
Tangsucharit, P
Loilome, W
2017
86. Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment Supak Yothaisong
Hasaya Dokduang
Naohiko Anzai
Keitaro Hayashi
Nisana Namwat
Puangrat Yongvanit
Sakkarn Sangkhamanon
Promsuk Jutabha
Hitoshi Endou
Watcharin Loilome
2017
87. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. Sureerat Padthaisong
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Aekkaphod Liwatthakun
Khittisak Hankla
Sakkarn Sangkhamanon
Watcharin Loilome
2017
88. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: An unresolved problem Thomas Hughes
Thomas O'Connor
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Ross H. Andrews-
Narong Khuntikeo
Puangrat Yongvanit
Paiboon Sithithaworn
Simon D. Taylor-Robinson
2017
89. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. Armartmuntree, N
Murata, M
Techasen, A
Yongvanit, P
Loilome, W
Namwat, N
Pairojkul, C
Sakonsinsiri, C
Pinlaor, S
Thanan, R
2017
90. Protein kinases as targets for Opisthorchis viverrini- associated cholangiocarcinoma therapy Loilome, W
Dokduang, H
2017
91. Simplified Techniques for Killing the Carcinogenic, Opisthorchis Viverrini Metacercariae in Cyprinid Fish Boonmars, T.
Songsri, J.
Aukkanimart, R.
Sriraj, P.
Rattanasuwan, P.
Suwannatrai, A.
Aunpromma, S.
Khuntikeo, N.
Loilome, W.
Namwat, N.
Yongvanit, P.
Boonjaraspinyo, S.
2017
92. Teleconsultation ultrasonography: A new weapon to combat cholangiocarcinoma Chamadol, N
Laopaiboon, V
Srinakarin, J
Loilome, W
Yongvanit, P
Thinkhamrop, B
Khuntikeo, N
2017
93. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Titapun, A.
Koonmee, S.
Loilome, W.
2017
94. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Nattaporn Phanthaphol
Anchalee Techasen
Watcharin Loilome
Suyanee Thongchot
Raynoo Thanan
Sakkarn Sungkhamanon
Narong Khuntikeo
Puangrat Yongvanit
Nisana Namwat
2017
95. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool. Jamnongkan, W.
Thanan, R.
Techasen, A.
Namwat, N.
Loilome, W.
Intarawichian, P.
Titapun, A.
Yongvanit, P.
2017
96. Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool Wassana Jamnongkan
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Piyapharom Intarawichian
Attapol Titapun
Puangrat Yongvanit
2017
97. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group. Loilome, W.
Yongvanit, P.
Thongchot, S.
Namwat, N.
Sithithaworn, P.
Boonmars, T.
Koonmee, S.
Titapun, A.
Khuntikeo, N.
Chamadol, N.
Techasen, A.
2017
98. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Rayno Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
Anchalee Techasen
2018
99. CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Nisana Namwat
Attapon Titapun
Narong Khuntikeo
Shogo Okazaki
Eiji Sugihara
Hideyuki Saya
Puangrat Yongvanit
2018
100. Cellular senescence and inhibitory effects of PRIMA-1MET in cholangiocarcinoma Chayanit Piyawajanusorn
Watcharin Loilome
Yingpinyapat Kittirat
Suyanee Thongchot
Nisana Namwat
2018
101. Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia. Khuntikeo, N.
Titapun, A.
Loilome,
Yongvanit, P.
Thinkhamrop, B.
Chamadol, N.
Boonmars, T.
Andrews, R.H.
Sithithaworn, P.
2018
102. Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis Eamudomkarn, C
Sithithaworn, P
Kamamia, C
Yakovleva, A
Sithithaworn, J
Kaewkes, S
Techasen, A
Loilome, W
Yongvanit, P
Wangboon, C
Saichua, P
Itoh, M
M Bethony, J
2018
103. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway Suyanee Thongchot
Chiara Vidoni
Alessandra Ferraresi
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
Ciro Isidoro
2018
104. Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis Anchalee Techasen
Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Raynoo Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
2018
105. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis. Yongvanit, P.
Loilome,
Thanan, R.
Eamudomkarn, C.
Chamadol, N.
Mairiang, E.
Sithithaworn, J.
Saichua, P.
Sripa, B.
Khuntikeo, N.
Sithithaworn, P.
2018
106. Erratum to “Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells” (Cancer Letters (2018) 430 (160–171), (S0304383518303641) (10.1016/j.canlet.2018.05.031)) Thongchot, S.
Loilome,
Yongvanit, P.
2018
107. Erratum to "Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells" [Cancer Letters 430C (2018) 160-171]. Thongchot, S
Ferraresi, A
Vidoni, C
Loilome, W
Yongvanit, P
Namwat, N
Isidoro, C
2018
108. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. Wangboon, C
Worasith, C
Thanan, R
Eamudomkarn, C
Techasen, A
Sithithaworn, J
Loilome, W
Chamadol, N
Pinlaor, S
Jumnainsong, A
Yongvanit, P
Khuntikeo, N
Bethony, JM
Sithithaworn, P
2018
109. Increasing of 5-lipoxygenase expression associated with cholangiocarcinoma development Sasikamon Korphai
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
2018
110. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. Manida Suksawat
Anchalee Techasen
Nisana Namwat
Thianrut Boonsong
Attapol Titapun
Piti Ungarreevittaya
Puangrat Yongvanit
Watcharin Loilome
2018
111. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy Techasen, A.
Namwat, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
2018
112. Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth Hasaya Dokduang
Manida Suksawat
Sureerat Padthaisong
Wassana Jamnongkarn
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Narong Khuntikeao
Watcharin Loilome
2018
113. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapol Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018
114. Oxidative stress down-regulates Early B cell factor 1 resulting in cholangiocarcinoma genesis Napat Armartmuntree
Mariko Murata
Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Chadamas Sakonsinsiri
Somchai Pinlaor
Raynoo Thanan
2018
115. Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018
116. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells Silakit, R
Kitirat, Y
Thongchot, S
Loilome, W
Techasen, A
Ungarreevittaya, P
Khuntikeo, N
Yongvanit, P
Yang, JH
Kim, NH
Yook, JI
Namwat, N
2018
117. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway Daya, M
Loilome, W
Techasen, A
Thanee, M
Sa-Ngiamwibool, P
Titapun, A
Yongvanit, P
Namwat, N
2018
118. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis Armartmuntree, N.
Techasen, A.
Yongvanit, P.
Loilome, W.
Pairojkul, C.
Sakonsinsiri, C.
Pinlaor, S.
Thanan, R.
2018
119. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells Thongchot, S.
Loilome,
Yongvanit, P.
2018
120. Resveratrol interrupts the pro -invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells (vol 430C, pg 160, 2018) Suyanee Thongchot
Alessandra Ferraresi
Chiara Vidoni
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
Ciro Isidoro
2018
121. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine Techasen, A.
Thongchot, S.
Loilome, W.
Thanan, R.
Yongvanit, P.
Titapun, A.
Khuntikeo, N.
Namwat, N.
2018
122. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. Kittirat, Y
Techasen, A
Thongchot, S
Loilome, W
Thanan, R
Yongvanit, P
Sungkhamanon, S
Titapun, A
Khuntikeo, N
Namwat, N
2018
123. Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine Yingpinyapat Kittirat
Anchalee Techasen
Suyanee Thongchot
Watcharin Loilome
Raynoo Thanan
Puangrat Yongvanit
Sakkarn Sungkhamanon
Attapol Titapun
Narong Khuntikeo
Nisana Namwat
2018
124. TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma Phongsaran Kimawaha
Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anchalee Techasen
2018
125. The Socioeconomic Burden of Cholangiocarcinoma Associated With Opisthorchis viverrini Sensu Lato Infection in Northeast Thailand: A Preliminary Analysis. Khuntikeo, N.
Thinkhamrop, B.
Andrews, R.H.
Yongvanit, P.
Loilome,
Chamadol, N.
Kosuwan, W.
Sithithaworn, P.
2018
126. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway Khophai, S
Thanee, M
Techasen, A
Namwat, N
Klanrit, P
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Loilome, W
2018
127. A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients Khuntikeo, N.
Koonmee, S.
Chamadol, N.
Laopaiboon, V.
Titapun, A.
Yongvanit, P.
Loilome,
Andrews, R.H.
Thinkhamrop, K.
Tawarungruang, C.
Thinkhamrop, B.
2019
128. Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma Sithithaworn, P.
Khuntikeo, N.
Loilome, W.
Yongvanit, P.
Chamadol, N.
Andrews, R.H.
2019
129. Cholangiocarcinoma: A guide for the nonspecialist Alsaleh, M
Leftley, Z
Barbera, TA
Sithithaworn, P
Khuntikeo, N
Loilome, W
Yongvanit, P
Cox, IJ
Chamodol, N
Syms, RR
Andrews, RH
Taylor-Robinson, SD
2019
130. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand Worasith, C
Wangboon, C
Duenngai, K
Kiatsopit, N
Kopolrat, K
Techasen, A
Sithithaworn, J
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
Carlton, EJ
Sithithaworn, P
2019
131. Detection of the G1138A mutation in the FGFR3 gene for the diagnosis of achondroplasia by allele-specific polymerase chain reaction Imtawil, K.J.
Loilome, W.
Tangrassameeprasert, R.
Wichajarn, K.
2019
132. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. Kassaporn Duangkumpha
Thomas Stoll
Jutarop Phetcharaburanin
Puangrat Yongvanit
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Nittaya Chamadol
Sittiruk Roytrakul
Jason Mulvenna
Ahmed Mohamed
Alok K. Shah
Michelle M. Hill
Watcharin Loilome
2019
133. Discovery of serotransferrin glycoforms: Novel markers for diagnosis of liver periductal fibrosis and prediction of cholangiocarcinoma Wassana Jamnongkan
Carlito B. Lebrilla
Mariana Barboza
Anchalee Techasen
Watcharin Loilome
Paiboon Sithithaworn
Narong Khuntikeo
Chawalit Pairojkul
Nittaya Chamadol
Raynoo Thanan
Puangrat Yongvanit
2019
134. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines Promraksa, B
Phetcharaburanin, J
Namwat, N
Techasen, A
Boonsiri, P
Loilome, W
2019
135. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG Thanan, R.
Eamudomkarn, C.
Techasen, A.
Sithithaworn, J.
Loilome,
Chamadol, N.
Pinlaor, S.
Jumnainsong, A.
Yongvanit, P.
Khuntikeo, N.
Sithithaworn, P.
2019
136. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. Klanrit,
Phetcharaburanin, J.
Khuntikeo, N.
Titapun, A.
Techasen, A.
Loilome,
2019
137. Mass Spectrometry: A Guide for the Clinician. Munirah Alsaleh
Thomas A. Barbera
Ross H. Andrews
Paiboon Sithithaworn
Narong Khuntikeo
Watcharin Loilome
Puangrat Yongvanit
Isobel J. Cox
Richard R. A. Syms
Elaine Holmes
Simon D. Taylor-Robinson
2019
138. PRIMA-1 Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells. Piyawajanusorn, C
Kittirat, Y
Sa-Ngiamwibool, P
Titapun, A
Loilome, W
Namwat, N
2019
139. PRIMA-1MET induces cellular senescence and apoptotic cell death in cholangiocarcinoma cells Chayanit Piyawajanusorn
Yingpinyapat Kittirat
Prakasit Sa-Ngiamwibool
Attapol Titapun
Watcharin Loilome
Nisana Namwat
2019
140. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis Duangkumpha, K.
Phetcharaburanin, J.
Yongvanit, P.
Thanan, R.
Techasen, A.
Khuntikeo, N.
Chamadol, N.
Mulvenna, J.P.
Loilome,
2019
141. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma Padthaisong, S
Thanee, M
Namwat, N
Phetcharaburanin, J
Klanrit, P
Khuntikeo, N
Titapun, A
Loilome, W
2020
142. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine. Jamnongkan, W.
Techasen, A.
Phetcharaburanin, J.
Sithithaworn, P.
Khuntikeo, N.
Mukdasai, S.
Sayasone, S.
Loilome, W.
Ngeontae, W.
2020
143. Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort. Sithithaworn, P.
Khuntikeo, N.
Loilome, W.
Yongvanit, P.
2020
144. Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma. Kimawaha, P
Jusakul, A
Junsawang, P
Loilome, W
Khuntikeo, N
Techasen, A
2020
145. Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy Thongchot, S.
Thanee, M.
Loilome, W.
Techasen, A.
Titapun, A.
Yongvanit, P.
Namwat, N.
2020
146. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma Sureerat Padthaisong
Malinee Thanee
Nisana Namwat
Jutarop Phetcharaburanin
Poramate Klanrit
Narong Khuntikeo
Attapol Titapun
Sakkarn Sungkhamanon
Hideyuki Saya
Watcharin Loilome
2020
Count 104 99 113 11

Title Authors Year Publication name Cited count
< 2015 2016 2017 2018 2019 2020 Total
1. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model Loilome, W.
Yongvanit, P.
Wongkham, C.
Tepsiri, N.N.
Sripa, B.
Sithithaworn, P.
Miwa, M.
2006 Molecular Carcinogenesis
5 (45), pp. 279-287
2. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines Namwat, N.
Amimanan, P.
Loilome, W.
Jearanaikoon, P.
Sripa, B.
Bhudhisawasdi, V.
Tassaneeyakul, W.
2008 Chemotherapy
5 (54), pp. 343-351
3. Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling Loilome, W. 2009 Journal of Neuro-Oncology
3 (94), pp. 359-366
4. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines Hahnvajanawong, C.
Boonyanugomol, W.
Nasomyon, T.
Loilome, W.
Namwat, N.
Anantachoke, N.
Tassaneeyakul, W.
Sripa, B.
Namwat, W.
Reutrakul, V.
2010 World Journal of Gastroenterology
18 (16), pp. 2235-2243
5. Erratum: Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling (Journal of Neuro-Oncology DOI:10.1007/s11060- 009-9885-5) Loilome, W. 2010 Journal of Neuro-Oncology
3 (97), pp. 459
6. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway Techasen, A.
Loilome, W.
Namwat, N.
Takahashi, E.
Puapairoj, A.
Miwa, M.
Saya, H.
Yongvanit, P.
2010 Cancer Science
3 (101), pp. 658-665
7. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases Namwat, N.
Puetkasichonpasutha, J.
Loilome, W.
Yongvanit, P.
Techasen, A.
Puapairoj, A.
Sripa, B.
Tassaneeyakul, W.
Khuntikeo, N.
Wongkham, S.
2011 Journal of Gastroenterology
5 (46), pp. 664-675
8. Mechanisms of oxysterol-induced carcinogenesis Jusakul, A.
Yongvanit, P.
Loilome, W.
Namwat, N.
2011 Lipids in Health and Disease
(10), pp.
9. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma Loilome, W.
Juntana, S.
Namwat, N.
Bhudhisawasdi, V.
Puapairoj, A.
Sripa, B.
Miwa, M.
Saya, H.
Yongvanit, P.
2011 International Journal of Cancer
1 (129), pp. 34-44
10. Anti-inflammatory agents suppress the prostaglandin e2 production and migration ability of Cholangiocarcinoma cell lines Jongthawin, J.
Techasen, A.
Loilome, W.
Yongvanit, P.
Namwat, N.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 47-51
11. Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasis Wonkchalee, O.
Boonmars, T.
Aromdee, C.
Laummaunwai, P.
Khunkitti, W.
Vaeteewoottacharn, K.
Sriraj, P.
Aukkanimart, R.
Loilome, W.
Chamgramol, Y.
Pairojkul, C.
Juasook, A.
Sudsarn, P.
2012 Parasitology Research
1 (111), pp. 353-359
12. Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis Juasook, A.
Boonmars, T.
Kaewkes, S.
Loilome, W.
Veteewuthacharn, K.
Yongvanit, P.
2012 Parasitology Research
6 (110), pp. 2271-2279
13. Cytokines Released from activated human macrophages induce epithelial mesenchymal transition markers of Cholangiocarcinoma cells Techasen, A.
Loilome, W.
Namwat, N.
Dokduang, H.
Jongthawin, J.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 115-118
14. Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma Boonjaraspinyo, S.
Boonmars, T.
Kaewkes, S.
Laummaunwai, P.
Pinlaor, S.
Loilome, W.
Yongvanit, P.
Puapairoj, A.
Bhudhisawasdi, V.
2012 Pathology and Oncology Research
2 (18), pp. 227-237
15. Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy Loilome, W. 2012 PLoS ONE
10 (7), pp.
16. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis Loilome, W.
Wechagama, P.
Namwat, N.
Jusakul, A.
Sripa, B.
Miwa, M.
Yongvanit, P.
2012 Parasitology International
1 (61), pp. 136-139
17. Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of Opisthorchiasis-associated cholangiocarcinoma Namwat, N.
Chusorn, P.
Loilome, W.
Techasen, A.
Puetkasichonpasutha, J.
Pairojkul, C.
Khuntikeo, N.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 65-69
18. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma Yongvanit, P.
Phanomsri, E.
Namwat, N.
Kampan, J.
Tassaneeyakul, W.
Loilome, W.
Puapairoj, A.
Khuntikeo, N.
2012 Parasitology International
1 (61), pp. 162-166
19. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma Jusakul, A.
Khuntikeo, N.
Ioannou, G.N.
Loilome, W.
Namwat, N.
Bhudhisawasdi, V.
Pugkhem, A.
Pairojkul, C.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 77-82
20. Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development Loilome, W.
Namwat, N.
Techasen, A.
Puapairoj, A.
Pinitsoontorn, C.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 59-64
21. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen Yongvanit, P.
Thanan, R.
Pinlaor, S.
Sithithaworn, P.
Loilome, W.
Namwat, N.
Techasen, A.
Dechakhamphu, S.
2012 Parasitology Research
5 (110), pp. 1969-1977
22. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes Jusakul, A.
Loilome, W.
Namwat, N.
Dechakhamphu, S.
Sukontawarin, P.
Pinlaor, S.
Lee, S.P.
Yongvanit, P.
2012 Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
1-2 (731), pp. 48-57
23. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis Techasen, A.
Loilome, W.
Namwat, N.
Duenngai, K.
Cha'on, U.
Thanan, R.
Sithithaworn, P.
Miwa, M.
Yongvanit, P.
2012 Parasitology International
1 (61), pp. 140-144
24. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma Boonjaraspinyo, S.
Boonmars, T.
Kaewkes, S.
Loilome, W.
Sithithaworn, P.
Yongvanit, P.
Bhudhisawasdi, V.
2012 Parasitology International
1 (61), pp. 145-150
25. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma Boonjaraspinyo, S.
Boonmars, T.
Loilome, W.
Sithithaworn, P.
Pinlaor, S.
Yongvanit, P.
Nielsen, P.S.
Pairojkul, C.
Khuntikeo, N.
2012 Tumor Biology
5 (33), pp. 1785-1802
26. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. Loilome, W.
Yooyuen, S.
Namwat, N.
Sithithaworn, P.
Puapairoj, A.
Kano, J.
Miwa, M.
Yongvanit, P.
2012 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (33), pp. 2289-2298
27. Suppression of PRKAR1A expression enhances antiproliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma Cells Loilome, W.
Juntana, S.
Pinitsoontorn, C.
Namwat, N.
Tassaneeyakul, W.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 143-147
28. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma Techasen, A.
Namwat, N.
Loilome, W.
Bungkanjana, P.
Khuntikeo, N.
Puapairoj, A.
Jearanaikoon, P.
Saya, H.
Yongvanit, P.
2012 Medical Oncology
5 (29), pp. 3083-3091
29. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol- resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma Jusakul, A.
Loilome, W.
Namwat, N.
Techasen, A.
Ioannou, G.N.
Yongvanit, P.
2013 Journal of Steroid Biochemistry and Molecular Biology
(138), pp. 368-375
30. Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine Juasook, A.
Boonmars, T.
Loilome, W.
Veteewuthacharn, K.
Namwat, N.
Namwat, N.
Sudsarn, P.
Wonkchalee, O.
Sriraj, P.
Aukkanimart, R.
2013 Pathology and Oncology Research
1 (19), pp. 55-62
31. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy Yothaisong, S.
Dokduang, H.
Techasen, A.
Namwat, N.
Yongvanit, P.
Bhudhisawasdi, V.
Puapairoj, A.
Loilome, W.
2013 Tumor Biology
6 (34), pp. 3637-3648
32. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis Chusorn, P.
Namwat, N.
Loilome, W.
Techasen, A.
Pairojkul, C.
Khuntikeo, N.
Talabnin, C.
Chan-On, W.
Yongvanit, P.
2013 Tumor Biology
3 (34), pp. 1579-1588
33. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma Jamnongkan, W.
Techasen, A.
Thanan, R.
Duenngai, K.
Sithithaworn, P.
Mairiang, E.
Loilome, W.
Namwat, N.
Pairojkul, C.
Yongvanit, P.
2013 Tumor Biology
2 (34), pp. 695-704
34. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment Dokduang, H.
Juntana, S.
Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Loilome, W.
2013 Tumor Biology
6 (34), pp. 3519-3528
35. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells Loilome, W.
Bungkanjana, P.
Techasen, A.
Namwat, N.
Yongvanit, P.
Puapairoj, A.
Khuntikeo, N.
2014 Tumor Biology
6 (35), pp. 5357-5367
36. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression Khenjanta, C.
Thanan, R.
Jusakul, A.
Techasen, A.
Jamnongkan, W.
Namwat, N.
Loilome, W.
Pairojkul, C.
Yongvanit, P.
2014 Asian Pacific Journal of Cancer Prevention
23 (15), pp. 10187-10192
37. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma Duangkumpha, K.
Techasen, A.
Loilome, W.
Namwat, N.
Thanan, R.
Khuntikeo, N.
Yongvanit, P.
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 9667-9676
38. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: A prospective prognostic indicator Loilome, W.
Yongvanit, P.
Chusorn, P.
Techasen, A.
Boonmars, T.
Khuntikeo, N.
Chamadol, N.
Pairojkul, C.
Namwat, N.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
12 (21), pp. 864-872
39. High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis Thongchot, S.
Yongvanit, P.
Loilome, W.
Seubwai, W.
Phunicom, K.
Tassaneeyakul, W.
Pairojkul, C.
Promkotra, W.
Techasen, A.
Namwat, N.
2014 Asian Pacific Journal of Cancer Prevention
14 (15), pp. 5873-5878
40. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients Chamadol, N.
Pairojkul, C.
Khuntikeo, N.
Laopaiboon, V.
Loilome, W.
Sithithaworn, P.
Yongvanit, P.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
5 (21), pp. 316-322
41. Increased EphB2 expression predicts cholangiocarcinoma metastasis Khansaard, W.
Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Puapairoj, A.
Loilome, W.
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 10031-10041
42. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis Techasen, A.
Loilome, W.
Namwat, N.
Khuntikeo, N.
Puapairoj, A.
Jearanaikoon, P.
Saya, H.
Yongvanit, P.
2014 Tumor Biology
9 (35), pp. 8645-8652
43. Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma Boonmars, T.
Loilome, W.
Yongvanit, P.
Khuntikeo, N.
Nielsen, P.S.
2014 Tumor Biology
3 (35), pp. 1985-1995
44. Opisthorchis viverrini infection activates the PI3K/AKT/PTEN and Wnt/β-catenin signaling pathways in a cholangiocarcinogenesis model Yothaisong, S.
Thanee, M.
Namwat, N.
Yongvanit, P.
Boonmars, T.
Puapairoj, A.
Loilome, W.
2014 Asian Pacific Journal of Cancer Prevention
23 (15), pp. 10463-10468
45. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jongthawin, J.
Chusorn, P.
Techasen, A.
Loilome, W.
Boonmars, T.
Thanan, R.
Puapairoj, A.
Khuntikeo, N.
Tassaneeyakul, W.
Yongvanit, P.
Namwat, N.
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
8 (35), pp. 8051-8064
46. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma Yongvanit, P.
Pinlaor, S.
Loilome, W.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
5 (21), pp. 309-315
47. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression Dokduang, H.
Techasen, A.
Namwat, N.
Khuntikeo, N.
Pairojkul, C.
Murakami, Y.
Loilome, W.
Yongvanit, P.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
10 (21), pp. 767-776
48. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression Techasen, A.
Namwat, N.
Loilome, W.
Duangkumpha, K.
Puapairoj, A.
Saya, H.
Yongvanit, P.
2014 Journal of Hepato-Biliary-Pancreatic Sciences
9 (21), pp. 703-711
49. A promising serum autoantibody marker, anti-heat shock protein 90α, for cholangiocarcinoma Boonjaraspinyo, S.
Juasook, A.
Boonmars, T.
Aukkanimart, R.
Silsirivanit, A.
Loilome, W.
Sriraj, P.
2015 Asian Pacific Journal of Cancer Prevention
14 (16), pp. 5779-5785
50. Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells Thongchot, S.
Loilome, W.
Yongvanit, P.
Dokduang, H.
Thanan, R.
Techasen, A.
Namwat, N.
2015 Asian Pacific Journal of Cancer Prevention
5 (16), pp. 2031-2035
51. Cohort profile: Cholangiocarcinoma screening and care program (CASCAP) Khuntikeo, N.
Chamadol, N.
Yongvanit, P.
Loilome, W.
Namwat, N.
Sithithaworn, P.
Andrews, R.H.
Petney, T.N.
Promthet, S.S.
Thinkhamrop, K.
Tawarungruang, C.
Thinkhamrop, B.
2015 BMC Cancer
1 (15), pp.
52. Quantitative changes in tumor-associated M2 Macrophages characterize cholangiocarcinoma and their association with metastasis Thanee, M.
Loilome, W.
Techasen, A.
Namwat, N.
Boonmars, T.
Pairojkul, C.
Yongvanit, P.
2015 Asian Pacific Journal of Cancer Prevention
7 (16), pp. 3043-3050
53. A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand Khuntikeo, N.
Loilome, W.
Thinkhamrop, B.
Chamadol, N.
Yongvanit, P.
2016 PLoS Neglected Tropical Diseases
1 (10), pp.
54. A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand Khuntikeo, N.
Loilome, W.
Thinkhamrop, B.
Chamadol, N.
Yongvanit, P.
2016 PLoS Neglected Tropical Diseases
1 (10), pp.
55. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Thanee, M.
Loilome, W.
Techasen, A.
Namwat, N.
Khuntikeo, N.
Titapun, A.
Pairojkul, C.
Saya, H.
Yongvanit, P.
2016 Cancer Science
(), pp.
56. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Thanee, M.
Loilome, W.
Techasen, A.
Namwat, N.
Khuntikeo, N.
Titapun, A.
Pairojkul, C.
Saya, H.
Yongvanit, P.
2016 Cancer Science
7 (107), pp. 991-1000
57. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma Sudsarn, P.
Boonmars, T.
Ruangjirachuporn, W.
Namwat, N.
Loilome, W.
Sriraj, P.
Aukkanimart, R.
Jiraporn, S.
2016 Pathology and Oncology Research
1 (22), pp. 57-65
58. Potential of selenium compounds as new anticancer agents for cholangiocarcinoma Thongchot, S.
Dokduang, H.
Loilome, W.
Khuntikeo, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
Techasen, A.
Namwat, N.
2016 Anticancer Research
11 (36), pp. 5981-5988
59. Xanthohumol inhibits STAT3 activation pathway leaDing to growth suppression and apoptosis induction in human cholangiocarcinoma cells Dokduang, H.
Yongvanit, P.
Namwat, N.
Pairojkul, C.
Loilome, W.
2016 Oncology Reports
4 (35), pp. 2065-2072
60. Carcinogenic liver fluke and others contaminated in pickled fish of northeastern Thailand Aukkanimart, R.
Boonmars, T.
Sriraj, P.
Songsri, J.
Laummaunwai, P.
Aunpromma, S.
Khuntikeo, N.
Loilome, W.
Namwat, N.
Yongvanit, P.
Boonjaraspinyo, S.
2017 Asian Pacific Journal of Cancer Prevention
2 (18), pp. 529-533
61. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand Senggunprai, L.
Namwat, N.
Kongpetch, S.
Chamgramol, Y.
Loilome, W.
Khansaard, W.
Jusakul, A.
Prawan, A.
Pairojkul, C.
Yongvanit, P.
Kukongviriyapan, V.
2017 Tumor Biology
11 (39), pp.
62. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma Loilome, W.
Yongvanit, P.
Namwat, N.
Techasen, A.
Khuntikeo, N.
2017 Oncology Letters
2 (13), pp. 639-646
63. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance Namwat, N.
Yongvanit, P.
Loilome, W.
Khuntikeo, N.
Tassaneeyakul, W.
Tangsucharit, P.
Yothaisong, S.
2017 Parasitology International
4 (66), pp. 471-478
64. Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment Yothaisong, S.
Dokduang, H.
Namwat, N.
Yongvanit, P.
Loilome, W.
2017 Tumor Biology
3 (39), pp.
65. Nimotuzumab inhibits cholangiocarcinoma cell metastasis via suppression of the epithelial-mesenchymal transition process Thanee, M.
Techasen, A.
Namwat, N.
Yongvanit, P.
Loilome, W.
2017 Anticancer Research
7 (37), pp. 3591-3597
66. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: An unresolved problem Techasen, A.
Loilome, W.
Khuntikeo, N.
Yongvanit, P.
Sithithaworn, P.
2017 International Journal of General Medicine
(10), pp. 227-237
67. Protein kinases as targets for Opisthorchis viverrini- associated cholangiocarcinoma therapy Loilome, W.
Dokduang, H.
2017 Current Pharmaceutical Design
29 (23), pp. 4281-4289
68. Simplified techniques for killing the carcinogenic, Opisthorchis viverrini metacercariae in cyprinid fish Boonmars, T.
Songsri, J.
Aukkanimart, R.
Sriraj, P.
Rattanasuwan, P.
Suwannatrai, A.
Aunpromma, S.
Khuntikeo, N.
Loilome, W.
Namwat, N.
Yongvanit, P.
Boonjaraspinyo, S.
2017 Asian Pacific Journal of Cancer Prevention
6 (18), pp. 1507-1511
69. Teleconsultation ultrasonography: A new weapon to combat cholangiocarcinoma Chamadol, N.
Laopaiboon, V.
Srinakarin, J.
Loilome,
Yongvanit, P.
Thinkhamrop, B.
Khuntikeo, N.
2017 ESMO Open
3 (2), pp.
70. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance Techasen, A.
Namwat, N.
Yongvanit, P.
Khuntikeo, N.
Titapun, A.
Koonmee, S.
Loilome, W.
2017 Parasitology International
4 (66), pp. 486-493
71. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Techasen, A.
Thongchot, S.
Thanan, R.
Khuntikeo, N.
Yongvanit, P.
2017 Oncology Letters
5 (14), pp. 5973-5979
72. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool Jamnongkan, W.
Thanan, R.
Techasen, A.
Namwat, N.
Loilome, W.
Intarawichian, P.
Titapun, A.
Yongvanit, P.
2017 Tumor Biology
7 (39), pp. 1-10
73. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group Loilome, W.
Yongvanit, P.
Thongchot, S.
Namwat, N.
Sithithaworn, P.
Boonmars, T.
Koonmee, S.
Titapun, A.
Khuntikeo, N.
Chamadol, N.
Techasen, A.
2017 Parasitology International
4 (66), pp. 479-485
74. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis Jamnongkan, W.
Thanee, M.
Yongvanit, P.
Loilome, W.
Thanan, R.
Namwat, N.
Techasen, A.
2018 PeerJ
1 (2018), pp.
75. Current perspectives on opisthorchiasis control and cholangiocarcinoma detection in Southeast Asia Khuntikeo, N.
Titapun, A.
Loilome,
Yongvanit, P.
Thinkhamrop, B.
Chamadol, N.
Boonmars, T.
Andrews, R.H.
Sithithaworn, P.
2018 Frontiers in Medicine
APR (5), pp.
76. Current perspectives on opisthorchiasis control and cholangiocarcinoma detection in southeast asia Khuntikeo, N.
Titapun, A.
Loilome,
Yongvanit, P.
Thinkhamrop, B.
Chamadol, N.
Boonmars, T.
Andrews, R.H.
Sithithaworn, P.
2018 Frontiers in Medicine
APR (5), pp.
77. Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis Eamudomkarn, C.
Sithithaworn, P.
Sithithaworn, J.
Kaewkes, S.
Techasen, A.
Loilome,
Yongvanit, P.
Saichua, P.
Itoh, M.
2018 PLoS ONE
7 (13), pp.
78. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway Thongchot, S.
Loilome,
Yongvanit, P.
2018 Molecular Carcinogenesis
12 (57), pp. 1735-1750
79. Elevated levels of urinary 8-oxodG correlate with persistent periductal fibrosis after praziquantel treatment in chronic opisthorchiasis Yongvanit, P.
Loilome,
Thanan, R.
Eamudomkarn, C.
Chamadol, N.
Mairiang, E.
Sithithaworn, J.
Saichua, P.
Sripa, B.
Khuntikeo, N.
Sithithaworn, P.
2018 American Journal of Tropical Medicine and Hygiene
6 (98), pp. 1763-1769
80. Erratum to “Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells” (Cancer Letters (2018) 430 (160–171), (S0304383518303641) (10.1016/j.canlet.2018.05.031)) Thongchot, S.
Loilome,
Yongvanit, P.
2018 Cancer Letters
(434), pp. 206-207
81. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy Techasen, A.
Namwat, N.
Titapun, A.
Ungarreevittaya, P.
Yongvanit, P.
2018 FEBS Open Bio
4 (8), pp. 513-522
82. Inhibitory effect of nvp-bkm120 on cholangiocarcinoma cell growth Dokduang, H.
Yothaisong, S.
Techasen, A.
Yongvanit, P.
Khuntikeo, N.
Titapun, A.
Loilome,
2018 Oncology Letters
2 (16), pp. 1627-1633
83. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells Thongchot, S.
Loilome,
Techasen, A.
Ungarreevittaya, P.
Khuntikeo, N.
Yongvanit, P.
2018 PLoS ONE
6 (13), pp.
84. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway Loilome, W.
Techasen, A.
Thanee, M.
Titapun, A.
Yongvanit, P.
Namwat, N.
2018 OncoTargets and Therapy
(11), pp. 395-408
85. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis Armartmuntree, N.
Techasen, A.
Yongvanit, P.
Loilome, W.
Pairojkul, C.
Sakonsinsiri, C.
Pinlaor, S.
Thanan, R.
2018 Redox Biology
(14), pp. 637-644
86. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells Thongchot, S.
Loilome,
Yongvanit, P.
2018 Cancer Letters
(430), pp. 160-171
87. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine Techasen, A.
Thongchot, S.
Loilome, W.
Thanan, R.
Yongvanit, P.
Titapun, A.
Khuntikeo, N.
Namwat, N.
2018 Oncology Letters
1 (15), pp. 347-353
88. The Socioeconomic Burden of Cholangiocarcinoma Associated With Opisthorchis viverrini Sensu Lato Infection in Northeast Thailand: A Preliminary Analysis Khuntikeo, N.
Thinkhamrop, B.
Andrews, R.H.
Yongvanit, P.
Loilome,
Chamadol, N.
Kosuwan, W.
Sithithaworn, P.
2018 Advances in Parasitology
(102), pp. 141-163
89. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway Thanee, M.
Techasen, A.
Klanrit,
Titapun, A.
Loilome,
2018 OncoTargets and Therapy
(11), pp. 7019-7029
90. A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients Khuntikeo, N.
Koonmee, S.
Chamadol, N.
Laopaiboon, V.
Titapun, A.
Yongvanit, P.
Loilome,
Andrews, R.H.
Thinkhamrop, K.
Tawarungruang, C.
Thinkhamrop, B.
2019 HPB
(), pp.
91. Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma Sithithaworn, P.
Khuntikeo, N.
Loilome, W.
Yongvanit, P.
Chamadol, N.
Andrews, R.H.
2019 Journal of Clinical and Experimental Hepatology
6 (9), pp. 657-675
92. Cholangiocarcinoma: A guide for the nonspecialist Sithithaworn, P.
Khuntikeo, N.
Loilome, W.
Yongvanit, P.
Andrews, R.H.
2019 International Journal of General Medicine
(12), pp. 13-23
93. Comparing the performance of urine and copro-antigen detection in evaluating opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand Duenngai, K.
Kiatsopit, N.
Kopolrat, K.
Techasen, A.
Sithithaworn, J.
Khuntikeo, N.
Loilome,
Yongvanit, P.
Sithithaworn, P.
2019 PLoS Neglected Tropical Diseases
2 (13), pp.
94. Detection of the G1138A mutation in the FGFR3 gene for the diagnosis of achondroplasia by allele-specific polymerase chain reaction Imtawil, K.J.
Loilome, W.
Tangrassameeprasert, R.
Wichajarn, K.
2019 Journal of the Medical Association of Thailand
6 (102), pp. 118-121
95. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis Duangkumpha, K.
Phetcharaburanin, J.
Yongvanit, P.
Thanan, R.
Techasen, A.
Khuntikeo, N.
Chamadol, N.
Mulvenna, J.P.
Loilome,
2019 Journal of Proteome Research
9 (18), pp. 3305-3316
96. Discovery of serotransferrin glycoforms: Novel markers for diagnosis of liver periductal fibrosis and prediction of cholangiocarcinoma Jamnongkan, W.
Techasen, A.
Loilome,
Sithithaworn, P.
Khuntikeo, N.
Pairojkul, C.
Chamadol, N.
Thanan, R.
Yongvanit, P.
2019 Biomolecules
10 (9), pp.
97. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines Promraksa, B.
Phetcharaburanin, J.
Techasen, A.
Boonsiri, P.
Loilome,
2019 PLoS ONE
5 (14), pp.
98. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG Thanan, R.
Eamudomkarn, C.
Techasen, A.
Sithithaworn, J.
Loilome,
Chamadol, N.
Pinlaor, S.
Jumnainsong, A.
Yongvanit, P.
Khuntikeo, N.
Sithithaworn, P.
2019 Acta Tropica
(189), pp. 124-128
99. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues Klanrit,
Phetcharaburanin, J.
Khuntikeo, N.
Titapun, A.
Techasen, A.
Loilome,
2019 PLoS ONE
9 (14), pp.
100. Mass Spectrometry: A Guide for the Clinician Andrews, R.H.
Sithithaworn, P.
Khuntikeo, N.
Loilome, W.
Yongvanit, P.
2019 Journal of Clinical and Experimental Hepatology
5 (9), pp. 597-606
101. PRIMA-1MET induces cellular senescence and apoptotic cell death in cholangiocarcinoma cells Titapun, A.
Loilome,
2019 Cancer Genomics and Proteomics
6 (16), pp. 543-552
102. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis Duangkumpha, K.
Phetcharaburanin, J.
Yongvanit, P.
Thanan, R.
Techasen, A.
Khuntikeo, N.
Chamadol, N.
Mulvenna, J.P.
Loilome,
2019 PLoS ONE
8 (14), pp.
103. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma Thanee, M.
Namwat, N.
Phetcharaburanin, J.
Klanrit, P.
Khuntikeo, N.
Titapun, A.
Loilome, W.
2020 BMC Cancer
1 (20), pp.
104. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine Jamnongkan, W.
Techasen, A.
Phetcharaburanin, J.
Sithithaworn, P.
Khuntikeo, N.
Mukdasai, S.
Sayasone, S.
Loilome, W.
Ngeontae, W.
2020 Talanta
(209), pp.
105. Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort Sithithaworn, P.
Khuntikeo, N.
Loilome, W.
Yongvanit, P.
2020 Journal of Clinical and Experimental Hepatology
1 (10), pp. 17-29
106. Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy Thongchot, S.
Thanee, M.
Loilome, W.
Techasen, A.
Titapun, A.
Yongvanit, P.
Namwat, N.
2020 Journal of Traditional and Complementary Medicine
(), pp.
107. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma Thanee, M.
Phetcharaburanin, J.
Klanrit, P.
Khuntikeo, N.
Titapun, A.
Saya, H.
Loilome, W.
2020 Journal of Translational Medicine
1 (18), pp.

Title Authors Year Journal title
1. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model. Loilome, W
Yongvanit, P
Wongkham, C
Tepsiri, N
Sripa, B
Sithithaworn, P
Hanai, S
Miwa, M
2006 Molecular carcinogenesis
5 (45), pp. 279-87
2. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines. Namwat, N
Amimanan, P
Loilome, W
Jearanaikoon, P
Sripa, B
Bhudhisawasdi, V
Tassaneeyakul, W
2008 Chemotherapy
5 (54), pp. 343-51
3. Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling. Loilome, W
Joshi, AD
ap Rhys, CM
Piccirillo, S
Vescovi, AL
Angelo, VL
Gallia, GL
Riggins, GJ
2009 Journal of neuro-oncology
3 (94), pp. 359-66
4. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Techasen, A
Loilome, W
Namwat, N
Takahashi, E
Sugihara, E
Puapairoj, A
Miwa, M
Saya, H
Yongvanit, P
2010 Cancer science
3 (101), pp. 658-65
5. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. Hahnvajanawong, C
Boonyanugomol, W
Nasomyon, T
Loilome, W
Namwat, N
Anantachoke, N
Tassaneeyakul, W
Sripa, B
Namwat, W
Reutrakul, V
2010 World journal of gastroenterology : WJG
18 (16), pp. 2235-43
6. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. Namwat, N
Puetkasichonpasutha, J
Loilome, W
Yongvanit, P
Techasen, A
Puapairoj, A
Sripa, B
Tassaneeyakul, W
Khuntikeo, N
Wongkham, S
2011 Journal of gastroenterology
5 (46), pp. 664-75
7. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma. Loilome, W
Juntana, S
Namwat, N
Bhudhisawasdi, V
Puapairoj, A
Sripa, B
Miwa, M
Saya, H
Riggins, GJ
Yongvanit, P
2011 International journal of cancer. Journal international du cancer
1 (129), pp. 34-44
8. Mechanisms of oxysterol-induced carcinogenesis. Jusakul, A
Yongvanit, P
Loilome, W
Namwat, N
Kuver, R
2011 Lipids in health and disease
(10), pp. 44
9. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. Jusakul, A
Loilome, W
Namwat, N
Haigh, WG
Kuver, R
Dechakhamphu, S
Sukontawarin, P
Pinlaor, S
Lee, SP
Yongvanit, P
2012 Mutation research
1 (731), pp. 48-57
10. Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy. Joshi, AD
Loilome, W
Siu, IM
Tyler, B
Gallia, GL
Riggins, GJ
2012 PloS one
10 (7), pp. e44372
11. Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of opisthorchiasis-associated cholangiocarcinoma. Namwat, N
Chusorn, P
Loilome, W
Techasen, A
Puetkasichonpasutha, J
Pairojkul, C
Khuntikeo, N
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 65-9
12. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. Loilome, W
Yooyuen, S
Namwat, N
Sithithaworn, P
Puapairoj, A
Kano, J
Noguchi, M
Miwa, M
Yongvanit, P
2012 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (33), pp. 2289-98
13. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. Techasen, A
Namwat, N
Loilome, W
Bungkanjana, P
Khuntikeo, N
Puapairoj, A
Jearanaikoon, P
Saya, H
Yongvanit, P
2012 Medical oncology (Northwood, London, England)
5 (29), pp. 3083-91
14. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma. Boonjaraspinyo, S
Boonmars, T
Wu, Z
Loilome, W
Sithithaworn, P
Nagano, I
Pinlaor, S
Yongvanit, P
Nielsen, PS
Pairojkul, C
Khuntikeo, N
2012 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
5 (33), pp. 1785-802
15. Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasis. Wonkchalee, O
Boonmars, T
Aromdee, C
Laummaunwai, P
Khunkitti, W
Vaeteewoottacharn, K
Sriraj, P
Aukkanimart, R
Loilome, W
Chamgramol, Y
Pairojkul, C
Wu, Z
Juasook, A
Sudsarn, P
2012 Parasitology research
1 (111), pp. 353-9
16. Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development. Loilome, W
Kadsanit, S
Namwat, N
Techasen, A
Puapairoj, A
Dechakhamphu, A
Pinitsoontorn, C
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 59-64
17. Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. Techasen, A
Loilome, W
Namwat, N
Dokduang, H
Jongthawin, J
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 115-8
18. Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines. Jongthawin, J
Techasen, A
Loilome, W
Yongvanit, P
Namwat, N
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 47-51
19. Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells. Loilome, W
Juntana, S
Pinitsoontorn, C
Namwat, N
Tassaneeyakul, W
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 143-7
20. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma. Jusakul, A
Khuntikeo, N
Haigh, WG
Kuver, R
Ioannou, GN
Loilome, W
Namwat, N
Bhudhisawasdi, V
Pugkhem, A
Pairojkul, C
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 77-82
21. Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis. Juasook, A
Boonmars, T
Kaewkes, S
Loilome, W
Veteewuthacharn, K
Wu, Z
Yongvanit, P
2012 Parasitology research
6 (110), pp. 2271-9
22. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen. Yongvanit, P
Thanan, R
Pinlaor, S
Sithithaworn, P
Loilome, W
Namwat, N
Techasen, A
Dechakhamphu, S
2012 Parasitology research
5 (110), pp. 1969-77
23. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. Boonjaraspinyo, S
Wu, Z
Boonmars, T
Kaewkes, S
Loilome, W
Sithithaworn, P
Nagano, I
Takahashi, Y
Yongvanit, P
Bhudhisawasdi, V
2012 Parasitology international
1 (61), pp. 145-50
24. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis. Techasen, A
Loilome, W
Namwat, N
Duenngai, K
Cha'on, U
Thanan, R
Sithithaworn, P
Miwa, M
Yongvanit, P
2012 Parasitology international
1 (61), pp. 140-4
25. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis. Loilome, W
Wechagama, P
Namwat, N
Jusakul, A
Sripa, B
Miwa, M
Kuver, R
Yongvanit, P
2012 Parasitology international
1 (61), pp. 136-9
26. Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma. Boonjaraspinyo, S
Boonmars, T
Kaewkes, S
Laummaunwai, P
Pinlaor, S
Loilome, W
Yongvanit, P
Wu, Z
Puapairoj, A
Bhudhisawasdi, V
2012 Pathology oncology research : POR
2 (18), pp. 227-37
27. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. Yongvanit, P
Phanomsri, E
Namwat, N
Kampan, J
Tassaneeyakul, W
Loilome, W
Puapairoj, A
Khuntikeo, N
2012 Parasitology international
1 (61), pp. 162-6
28. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. Jusakul, A
Loilome, W
Namwat, N
Techasen, A
Kuver, R
Ioannou, GN
Savard, C
Haigh, WG
Yongvanit, P
2013 The Journal of steroid biochemistry and molecular biology
(138), pp. 368-75
29. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Yothaisong, S
Dokduang, H
Techasen, A
Namwat, N
Yongvanit, P
Bhudhisawasdi, V
Puapairoj, A
Riggins, GJ
Loilome, W
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (34), pp. 3637-48
30. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment. Dokduang, H
Juntana, S
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Riggins, GJ
Loilome, W
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (34), pp. 3519-28
31. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Chusorn, P
Namwat, N
Loilome, W
Techasen, A
Pairojkul, C
Khuntikeo, N
Dechakhamphu, A
Talabnin, C
Chan-On, W
Ong, CK
Teh, BT
Yongvanit, P
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
3 (34), pp. 1579-88
32. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma. Jamnongkan, W
Techasen, A
Thanan, R
Duenngai, K
Sithithaworn, P
Mairiang, E
Loilome, W
Namwat, N
Pairojkul, C
Yongvanit, P
2013 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
2 (34), pp. 695-704
33. Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine. Juasook, A
Boonmars, T
Wu, Z
Loilome, W
Veteewuthacharn, K
Namwat, N
Sudsarn, P
Wonkchalee, O
Sriraj, P
Aukkanimart, R
2013 Pathology oncology research : POR
1 (19), pp. 55-62
34. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. Yongvanit, P
Pinlaor, S
Loilome, W
2014 Journal of hepato-biliary-pancreatic sciences
5 (21), pp. 309-15
35. Increased EphB2 expression predicts cholangiocarcinoma metastasis. Khansaard, W
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Puapairoj, A
Loilome, W
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 10031-41
36. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma. Duangkumpha, K
Techasen, A
Loilome, W
Namwat, N
Thanan, R
Khuntikeo, N
Yongvanit, P
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
10 (35), pp. 9667-76
37. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. Techasen, A
Namwat, N
Loilome, W
Duangkumpha, K
Puapairoj, A
Saya, H
Yongvanit, P
2014 Journal of hepato-biliary-pancreatic sciences
9 (21), pp. 703-11
38. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. Techasen, A
Loilome, W
Namwat, N
Khuntikeo, N
Puapairoj, A
Jearanaikoon, P
Saya, H
Yongvanit, P
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
9 (35), pp. 8645-52
39. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression. Jongthawin, J
Chusorn, P
Techasen, A
Loilome, W
Boonmars, T
Thanan, R
Puapairoj, A
Khuntikeo, N
Tassaneeyakul, W
Yongvanit, P
Namwat, N
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
8 (35), pp. 8051-64
40. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients. Chamadol, N
Pairojkul, C
Khuntikeo, N
Laopaiboon, V
Loilome, W
Sithithaworn, P
Yongvanit, P
2014 Journal of hepato-biliary-pancreatic sciences
5 (21), pp. 316-22
41. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. Loilome, W
Bungkanjana, P
Techasen, A
Namwat, N
Yongvanit, P
Puapairoj, A
Khuntikeo, N
Riggins, GJ
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
6 (35), pp. 5357-67
42. Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma. Wu, Z
Boonmars, T
Nagano, I
Loilome, W
Yongvanit, P
Khuntikeo, N
Nielsen, PS
Paorojkul, C
Takahashi, Y
Maekawa, Y
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
3 (35), pp. 1985-95
43. Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. Miwa, M
Honjo, S
You, G
Tanaka, M
Uchida, K
Srivatanakul, P
Khuhaprema, T
Loilome, W
Techasen, A
Wongkham, C
Limpaiboon, T
Yongvanit, P
Wongkham, S
2014 World journal of gastrointestinal pathophysiology
4 (5), pp. 570-8
44. Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model. Yothaisong, S
Thanee, M
Namwat, N
Yongvanit, P
Boonmars, T
Puapairoj, A
Loilome, W
2014 Asian Pacific journal of cancer prevention : APJCP
23 (15), pp. 10463-8
45. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. Khenjanta, C
Thanan, R
Jusakul, A
Techasen, A
Jamnongkan, W
Namwat, N
Loilome, W
Pairojkul, C
Yongvanit, P
2014 Asian Pacific journal of cancer prevention : APJCP
23 (15), pp. 10187-92
46. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator. Silakit, R
Loilome, W
Yongvanit, P
Chusorn, P
Techasen, A
Boonmars, T
Khuntikeo, N
Chamadol, N
Pairojkul, C
Namwat, N
2014 Journal of hepato-biliary-pancreatic sciences
12 (21), pp. 864-72
47. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. Thongchot, S
Yongvanit, P
Loilome, W
Seubwai, W
Phunicom, K
Tassaneeyakul, W
Pairojkul, C
Promkotra, W
Techasen, A
Namwat, N
2014 Asian Pacific journal of cancer prevention : APJCP
14 (15), pp. 5873-8
48. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression. Dokduang, H
Techasen, A
Namwat, N
Khuntikeo, N
Pairojkul, C
Murakami, Y
Loilome, W
Yongvanit, P
2014 Journal of hepato-biliary-pancreatic sciences
10 (21), pp. 767-76
49. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. Worasith, C
Kamamia, C
Yakovleva, A
Duenngai, K
Wangboon, C
Sithithaworn, J
Watwiengkam, N
Namwat, N
Techasen, A
Loilome, W
Yongvanit, P
Loukas, A
Sithithaworn, P
Bethony, JM
2015 PLoS neglected tropical diseases
10 (9), pp. e0004157
50. Cohort profile: cholangiocarcinoma screening and care program (CASCAP). ,
Khuntikeo, N
Chamadol, N
Yongvanit, P
Loilome, W
Namwat, N
Sithithaworn, P
Andrews, RH
Petney, TN
Promthet, S
Thinkhamrop, K
Tawarungruang, C
Thinkhamrop, B
,
,
,
,
,
,
,
,
,
2015 BMC cancer
(15), pp. 459
51. A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma. Boonjaraspinyo, S
Juasook, A
Boonmars, T
Aukkanimart, R
Silsirivanit, A
Loilome, W
Sriraj, P
Wu, Z
Ratanasuwan, P
2015 Asian Pacific journal of cancer prevention : APJCP
14 (16), pp. 5779-85
52. Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. Thanee, M
Loilome, W
Techasen, A
Namwat, N
Boonmars, T
Pairojkul, C
Yongvanit, P
2015 Asian Pacific journal of cancer prevention : APJCP
7 (16), pp. 3043-50
53. Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells. Thongchot, S
Loilome, W
Yongvanit, P
Dokduang, H
Thanan, R
Techasen, A
Namwat, N
2015 Asian Pacific journal of cancer prevention : APJCP
5 (16), pp. 2031-5
54. A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand. Khuntikeo, N
Loilome, W
Thinkhamrop, B
Chamadol, N
Yongvanit, P
2016 PLoS neglected tropical diseases
1 (10), pp. e0004293
55. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma. Sudsarn, P
Boonmars, T
Ruangjirachuporn, W
Namwat, N
Loilome, W
Sriraj, P
Aukkanimart, R
Nadchanan, W
Jiraporn, S
2016 Pathology oncology research : POR
1 (22), pp. 57-65
56. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. Thanee, M
Loilome, W
Techasen, A
Sugihara, E
Okazaki, S
Abe, S
Ueda, S
Masuko, T
Namwat, N
Khuntikeo, N
Titapun, A
Pairojkul, C
Saya, H
Yongvanit, P
2016 Cancer science
7 (107), pp. 991-1000
57. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. Dokduang, H
Yongvanit, P
Namwat, N
Pairojkul, C
Sangkhamanon, S
Yageta, MS
Murakami, Y
Loilome, W
2016 Oncology reports
4 (35), pp. 2065-72
58. Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma. Dai, X
Thongchot, S
Dokduang, H
Loilome, W
Khuntikeo, N
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Techasen, A
Namwat, N
2016 Anticancer research
11 (36), pp. 5981-5988
59. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. Armartmuntree, N
Murata, M
Techasen, A
Yongvanit, P
Loilome, W
Namwat, N
Pairojkul, C
Sakonsinsiri, C
Pinlaor, S
Thanan, R
2017 Redox biology
(14), pp. 637-644
60. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group. Silakit, R
Loilome, W
Yongvanit, P
Thongchot, S
Sithithaworn, P
Boonmars, T
Koonmee, S
Titapun, A
Khuntikeo, N
Chamadol, N
Techasen, A
Namwat, N
2017 Parasitology international
4 (66), pp. 479-485
61. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance. Yothaisong, S
Namwat, N
Yongvanit, P
Khuntikeo, N
Puapairoj, A
Jutabha, P
Anzai, N
Tassaneeyakul, W
Tangsucharit, P
Loilome, W
2017 Parasitology international
4 (66), pp. 471-478
62. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. Suksawat, M
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Titapun, A
Koonmee, S
Loilome, W
2017 Parasitology international
4 (66), pp. 486-493
63. Carcinogenic Liver Fluke and Others Contaminated in Pickled Fish of Northeastern Thailand Aukkanimart, R
Boonmars, T
Sriraj, P
Sripan, P
Songsri, J
Ratanasuwan, P
Laummaunwai, P
Suwanantrai, A
Aunpromma, S
Khueangchaingkhwang, S
Pumhirunroj, B
Artchayasawat, A
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
Boonjaraspinyo, S
2017 Asian Pacific journal of cancer prevention : APJCP
2 (18), pp. 529-533
64. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma. Loilome, W
Kadsanit, S
Muisook, K
Yongvanit, P
Namwat, N
Techasen, A
Puapairoj, A
Khuntikeo, N
Phonjit, P
2017 Oncology letters
2 (13), pp. 639-646
65. Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment. Yothaisong, S
Dokduang, H
Anzai, N
Hayashi, K
Namwat, N
Yongvanit, P
Sangkhamanon, S
Jutabha, P
Endou, H
Loilome, W
2017 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
3 (39), pp. 1010428317694545
66. Simplified Techniques for Killing the Carcinogenic, Opisthorchis Viverrini Metacercariae in Cyprinid Fish Sripan, P
Boonmars, T
Songsri, J
Aukkanimart, R
Sriraj, P
Rattanasuwan, P
Boueroy, P
Suwannatrai, A
Aunpromma, S
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
PhyoWai, A
Khueangchaingkhwang, S
Zhilang, W
Pumhirunroj, B
Artchayasawat, A
Boonjaraspinyo, S
2017 Asian Pacific journal of cancer prevention : APJCP
6 (18), pp. 1507-1511
67. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. Padthaisong, S
Thanee, M
Techasen, A
Namwat, N
Yongvanit, P
Liwatthakun, A
Hankla, K
Sangkhamanon, S
Loilome, W
2017 Anticancer research
7 (37), pp. 3591-3597
68. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool. Jamnongkan, W
Thanan, R
Techasen, A
Namwat, N
Loilome, W
Intarawichian, P
Titapun, A
Yongvanit, P
2017 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
7 (39), pp. 1010428317717655
69. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem. Hughes, T
O'Connor, T
Techasen, A
Namwat, N
Loilome, W
Andrews, RH
Khuntikeo, N
Yongvanit, P
Sithithaworn, P
Taylor-Robinson, SD
2017 International journal of general medicine
(10), pp. 227-237
70. Teleconsultation ultrasonography: a new weapon to combat cholangiocarcinoma. Chamadol, N
Laopaiboon, V
Srinakarin, J
Loilome, W
Yongvanit, P
Thinkhamrop, B
Khuntikeo, N
2017 ESMO open
3 (2), pp. e000231
71. Protein Kinases as Targets for Opisthorchis viverrini- Associated Cholangiocarcinoma Therapy. Loilome, W
Dokduang, H
2017 Current pharmaceutical design
29 (23), pp. 4281-4289
72. Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis. Eamudomkarn, C
Sithithaworn, P
Kamamia, C
Yakovleva, A
Sithithaworn, J
Kaewkes, S
Techasen, A
Loilome, W
Yongvanit, P
Wangboon, C
Saichua, P
Itoh, M
M Bethony, J
2018 PloS one
7 (13), pp. e0192598
73. The Socioeconomic Burden of Cholangiocarcinoma Associated With Opisthorchis viverrini Sensu Lato Infection in Northeast Thailand: A Preliminary Analysis. Khuntikeo, N
Thinkhamrop, B
Bundhamcharoen, K
Andrews, RH
Grundy-Warr, C
Yongvanit, P
Loilome, W
Chamadol, N
Kosuwan, W
Sithithaworn, P
Petney, TN
2018 Advances in parasitology
(102), pp. 141-163
74. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. Khophai, S
Thanee, M
Techasen, A
Namwat, N
Klanrit, P
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Loilome, W
2018 OncoTargets and therapy
(11), pp. 7019-7029
75. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. Jamnongkan, W
Thanee, M
Yongvanit, P
Loilome, W
Thanan, R
Kimawaha, P
Boonmars, T
Silakit, R
Namwat, N
Techasen, A
2018 PeerJ
(6), pp. e4281
76. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway. Thongchot, S
Vidoni, C
Ferraresi, A
Loilome, W
Yongvanit, P
Namwat, N
Isidoro, C
2018 Molecular carcinogenesis
12 (57), pp. 1735-1750
77. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. Wangboon, C
Worasith, C
Thanan, R
Eamudomkarn, C
Techasen, A
Sithithaworn, J
Loilome, W
Chamadol, N
Pinlaor, S
Jumnainsong, A
Yongvanit, P
Khuntikeo, N
Bethony, JM
Sithithaworn, P
2018 Acta tropica
(189), pp. 124-128
78. Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. Kittirat, Y
Techasen, A
Thongchot, S
Loilome, W
Thanan, R
Yongvanit, P
Sungkhamanon, S
Titapun, A
Khuntikeo, N
Namwat, N
2018 Oncology letters
1 (15), pp. 347-353
79. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. Daya, M
Loilome, W
Techasen, A
Thanee, M
Sa-Ngiamwibool, P
Titapun, A
Yongvanit, P
Namwat, N
2018 OncoTargets and therapy
(11), pp. 395-408
80. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. Suksawat, M
Techasen, A
Namwat, N
Boonsong, T
Titapun, A
Ungarreevittaya, P
Yongvanit, P
Loilome, W
2018 FEBS open bio
4 (8), pp. 513-522
81. Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia. Khuntikeo, N
Titapun, A
Loilome, W
Yongvanit, P
Thinkhamrop, B
Chamadol, N
Boonmars, T
Nethanomsak, T
Andrews, RH
Petney, TN
Sithithaworn, P
2018 Frontiers in medicine
(5), pp. 117
82. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. Thongchot, S
Ferraresi, A
Vidoni, C
Loilome, W
Yongvanit, P
Namwat, N
Isidoro, C
2018 Cancer letters
(430), pp. 160-171
83. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis. Wangboon, C
Yongvanit, P
Loilome, W
Thanan, R
Worasith, C
Eamudomkarn, C
Chamadol, N
Mairiang, E
Sithithaworn, J
Saichua, P
Sripa, B
Khuntikeo, N
Bethony, JM
Sithithaworn, P
2018 The American journal of tropical medicine and hygiene
6 (98), pp. 1763-1769
84. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. Silakit, R
Kitirat, Y
Thongchot, S
Loilome, W
Techasen, A
Ungarreevittaya, P
Khuntikeo, N
Yongvanit, P
Yang, JH
Kim, NH
Yook, JI
Namwat, N
2018 PloS one
6 (13), pp. e0199827
85. Erratum to "Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells" [Cancer Letters 430C (2018) 160-171]. Thongchot, S
Ferraresi, A
Vidoni, C
Loilome, W
Yongvanit, P
Namwat, N
Isidoro, C
2018 Cancer letters
(434), pp. 206-207
86. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. Padthaisong, S
Dokduang, H
Yothaisong, S
Techasen, A
Namwat, N
Yongvanit, P
Khuntikeo, N
Titapun, A
Sangkhamanon, S
Loilome, W
2018 Oncology letters
2 (16), pp. 1627-1633
87. Cholangiocarcinoma: a guide for the nonspecialist. Alsaleh, M
Leftley, Z
Barbera, TA
Sithithaworn, P
Khuntikeo, N
Loilome, W
Yongvanit, P
Cox, IJ
Chamodol, N
Syms, RR
Andrews, RH
Taylor-Robinson, SD
2019 International journal of general medicine
(12), pp. 13-23
88. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines. Promraksa, B
Phetcharaburanin, J
Namwat, N
Techasen, A
Boonsiri, P
Loilome, W
2019 PloS one
5 (14), pp. e0216721
89. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand. Worasith, C
Wangboon, C
Duenngai, K
Kiatsopit, N
Kopolrat, K
Techasen, A
Sithithaworn, J
Khuntikeo, N
Loilome, W
Namwat, N
Yongvanit, P
Carlton, EJ
Sithithaworn, P
2019 PLoS neglected tropical diseases
2 (13), pp. e0007186
90. Mass Spectrometry: A Guide for the Clinician. Alsaleh, M
Barbera, TA
Andrews, RH
Sithithaworn, P
Khuntikeo, N
Loilome, W
Yongvanit, P
Cox, IJ
Syms, RRA
Holmes, E
Taylor-Robinson, SD
2019 Journal of clinical and experimental hepatology
5 (9), pp. 597-606
91. PRIMA-1 Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells. Piyawajanusorn, C
Kittirat, Y
Sa-Ngiamwibool, P
Titapun, A
Loilome, W
Namwat, N
2019 Cancer genomics & proteomics
6 (16), pp. 543-552
92. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. Suksawat, M
Klanrit, P
Phetcharaburanin, J
Namwat, N
Khuntikeo, N
Titapun, A
Jarearnrat, A
Sa-Ngiamwibool, P
Techasen, A
Loilome, W
2019 PloS one
9 (14), pp. e0222140
93. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. Duangkumpha, K
Stoll, T
Phetcharaburanin, J
Yongvanit, P
Thanan, R
Techasen, A
Namwat, N
Khuntikeo, N
Chamadol, N
Roytrakul, S
Mulvenna, J
Mohamed, A
Shah, AK
Hill, MM
Loilome, W
2019 Journal of proteome research
9 (18), pp. 3305-3316
94. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis. Duangkumpha, K
Stoll, T
Phetcharaburanin, J
Yongvanit, P
Thanan, R
Techasen, A
Namwat, N
Khuntikeo, N
Chamadol, N
Roytrakul, S
Mulvenna, J
Mohamed, A
Shah, AK
Hill, MM
Loilome, W
2019 PloS one
8 (14), pp. e0221024
95. Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma. Kimawaha, P
Jusakul, A
Junsawang, P
Loilome, W
Khuntikeo, N
Techasen, A
2020 Journal of gastrointestinal oncology
2 (11), pp. 304-318
96. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma. Padthaisong, S
Thanee, M
Namwat, N
Phetcharaburanin, J
Klanrit, P
Khuntikeo, N
Titapun, A
Loilome, W
2020 BMC cancer
1 (20), pp. 154
97. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. Padthaisong, S
Thanee, M
Namwat, N
Phetcharaburanin, J
Klanrit, P
Khuntikeo, N
Titapun, A
Sungkhamanon, S
Saya, H
Loilome, W
2020 Journal of translational medicine
1 (18), pp. 64
98. Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort. Alsaleh, M
Leftley, Z
Barbera, TA
Koomson, LK
Zabron, A
Crossey, MME
Reeves, HL
Cramp, M
Ryder, S
Greer, S
Prince, M
Sithithaworn, P
Shariff, M
Khuntikeo, N
Loilome, W
Yongvanit, P
Shen, YL
Cox, IJ
Williams, R
Wadsworth, CA
Holmes, E
Nash, K
Taylor-Robinson, SD
2020 Journal of clinical and experimental hepatology
1 (10), pp. 17-29
99. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine. Taron, W
Jamnongkan, W
Techasen, A
Phetcharaburanin, J
Namwat, N
Sithithaworn, P
Khuntikeo, N
Mukdasai, S
Sayasone, S
Loilome, W
Ngeontae, W
2020 Talanta
(209), pp. 120592

Title Authors Year Journal title Cited count
< 2015 2016 2017 2018 2019 2020 Total
1. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model W Loilome
P Yongvanit
C Wongkham
N Tepsiri
B Sripa
P Sithithaworn
S Hanai
M Miwa
2006 MOLECULAR CARCINOGENESIS
5.0 (45.0), pp. 279.0-287.0
80 0 0 0 0 0 80
2. Altered gene expression levels associating with 5-fluorouracil resistance in cholangiocarcinoma cell lines Nisana N. Tepsiri
Watcharin Loilome
Piyawan Amimanan
Patcharee Jearanaikoon
Wichittra Tassaneeyakul
2006 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(21.0), pp. A95-A95
0 0 0 0 0 0 0
3. Plasma 8-isoprostane: a new biomarker in opisthorchiasis-associated cholangiocarcinoma Puangrat Yongvanit
Somkid Dechakhamphu
Somchai Pinlaor
Nisana N. Tepsiri
Watcharin Loilome
Narong Khantekaew
Paiboon Sithithaworn
2006 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(21.0), pp. A187-A188
0 0 0 0 0 0 0
4. Prkar1a gene overexpression in liver tissue with cholangiocarcinoma Watcharin Loilome
Anucha Puapairoj
Nisana N. Tepsiri
Paiboon Sithithaworn
Masanao Miwa
Puangrat Yongvanit
2006 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(21.0), pp. A188-A188
0 0 0 0 0 0 0
5. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines Nisana Namwat
Piyawan Amimanan
Watcharin Loilome
Patcharee Jearanaikoon
Banchob Sripa
Vajarabhongsa Bhudhisawasdi
Wichittra Tassaneeyakul
2008 CHEMOTHERAPY
5.0 (54.0), pp. 343.0-351.0
48 0 0 0 0 0 48
6. Over-expression of PRKAR1A in hepatic progenitor cells during cholangiocarcinogenesis induced by liver fluke (Opisthorchis, viverrini) P. Yonavanit
N. Namwat
W. Loilome
R. Thanan
E. Phanomsri
C. Pairojkul
2008 EJC SUPPLEMENTS
9.0 (6.0), pp. 132.0-133.0
0 0 0 0 0 0 0
7. Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling Watcharin Loilome
Avadhut D. Joshi
Colette M. J. ap Rhys
Sara Piccirillo
Vescovi L. Angelo
Gary L. Gallia
Gregory J. Riggins
2009 JOURNAL OF NEURO-ONCOLOGY
3.0 (94.0), pp. 359.0-366.0
61 0 0 0 0 0 61
8. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines Chariya Hahnvajanawong
Wongwarut Boonyanugomol
Tapanawan Nasomyon
Watcharin Loilome
Nisana Namwat
Natthinee Anantachoke
Wichittra Tassaneeyakul
Banchob Sripa
Wises Namwat
Vichai Reutrakul
2010 WORLD JOURNAL OF GASTROENTEROLOGY
18.0 (16.0), pp. 2235.0-2243.0
39 0 0 0 0 0 39
9. Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling (vol 94, pg 359, 2009) Watcharin Loilome
Avadhut D. Joshi
Colette M. J. ap Rhys
Sara Piccirillo
Angelo L. Vescovi
Gary L. Gallia
Gregory J. Riggins
2010 JOURNAL OF NEURO-ONCOLOGY
3.0 (97.0), pp. 459.0-459.0
0 0 0 0 0 0 0
10. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Eri Takahashi
Eiji Sugihara
Anucha Puapairoj
Masanao Miwa
Hideyuki Saya
Puangrat Yongvanit
2010 CANCER SCIENCE
3.0 (101.0), pp. 658.0-665.0
74 0 0 0 0 0 74
11. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases N. Namwat
J. Puetkasichonpasutha
W. Loilome
P. Yongvanit
A. Techasen
A. Puapairoj
B. Sripa
W. Tassaneeyakul
N. Khuntikeo
S. Wongkham
2011 JOURNAL OF GASTROENTEROLOGY
5.0 (46.0), pp. 664.0-675.0
53 0 0 0 0 0 53
12. Mechanisms of oxysterol-induced carcinogenesis Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Rahul Kuver
2011 LIPIDS IN HEALTH AND DISEASE
(10.0), pp.
58 0 0 0 0 0 58
13. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma Watcharin Loilome
Sirinun Juntana
Nisana Namwat
Vajarabhongsa Bhudhisawasdi
Anucha Puapairoj
Banchob Sripa
Masanao Miwa
Hideyuki Saya
Gregory J. Riggins
Puangrat Yongvanit
2011 INTERNATIONAL JOURNAL OF CANCER
1.0 (129.0), pp. 34.0-44.0
58 0 0 0 0 0 58
14. Anti-inflammatory Agents Suppress the Prostaglandin E-2 Production and Migration Ability of Cholangiocarcinoma Cell Lines Jurairat Jongthawin
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 47.0-51.0
17 0 0 0 0 0 17
15. Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasis Orasa Wonkchalee
Thidarut Boonmars
Chantana Aromdee
Porntip Laummaunwai
Watcharee Khunkitti
Kulthida Vaeteewoottacharn
Pranee Sriraj
Ratchadawan Aukkanimart
Watchalin Loilome
Yaovaluk Chamgramol
Chawalit Pairojkul
Zhiliang Wu
Amornrat Juasook
Pakkayanee Sudsarn
2012 PARASITOLOGY RESEARCH
1.0 (111.0), pp. 353.0-359.0
32 0 0 0 0 0 32
16. Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis Amornrat Juasook
Thidarut Boonmars
Sasithorn Kaewkes
Watcharin Loilome
Kulathida Veteewuthacharn
Zhiliang Wu
Puangrat Yongvanit
2012 PARASITOLOGY RESEARCH
6.0 (110.0), pp. 2271.0-2279.0
10 0 0 0 0 0 10
17. Cytokines Released from Activated Human Macrophages Induce Epithelial Mesenchymal Transition Markers of Cholangiocarcinoma Cells Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Hasaya Dokduang
Jurairat Jongthawin
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 115.0-118.0
51 0 0 0 0 0 51
18. Down-Regulated Expression of HSP70 in Correlation with Clinicopathology of Cholangiocarcinoma Sirintip Boonjaraspinyo
Thidarut Boonmars
Sasithorn Kaewkes
Porntip Laummaunwai
Somchai Pinlaor
Watchalin Loilome
Puangrat Yongvanit
Zhiliang Wu
Anucha Puapairoj
Vajarabhongsa Bhudhisawasdi
2012 PATHOLOGY & ONCOLOGY RESEARCH
2.0 (18.0), pp. 227.0-237.0
17 0 0 0 0 0 17
19. Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy Avadhut D. Joshi
Watcharin Loilome
I-Mei Siu
Betty Tyler
Gary L. Gallia
Gregory J. Riggins
2012 PLOS ONE
10.0 (7.0), pp.
42 0 0 0 0 0 42
20. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis Watcharin Loilome
Pairoj Wechagama
Nisana Namwat
Apinya Jusakul
Banchob Sripa
Masanao Miwa
Rahul Kuver
Puangrat Yongvanit
2012 PARASITOLOGY INTERNATIONAL
1.0 (61.0), pp. 136.0-139.0
23 0 0 0 0 0 23
21. Expression Profiles of Oncomir miR-21 and Tumor Suppressor let-7a in the Progression of Opisthorchiasis-Associated Cholangiocarcinoma N. Namwat
P. Chusorn
W. Loilome
A. Techasen
J. Puetkasichonpasutha
C. Pairojkul
N. Khuntikeo
P. Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 65.0-69.0
25 0 0 0 0 0 25
22. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma Puangrat Yongvanit
Emorn Phanomsri
Nisana Namwat
Jureeporn Kampan
Wichittra Tassaneeyakul
Watcharin Loilome
Anucha Puapairoj
Narong Khuntikeo
2012 PARASITOLOGY INTERNATIONAL
1.0 (61.0), pp. 162.0-166.0
7 0 0 0 0 0 7
23. Identification of Biliary Bile Acids in Patients with Benign Biliary Diseases, Hepatocellular Carcinoma and Cholangiocarcinoma Apinya Jusakul
Narong Khuntikeo
W. Geoffrey Haigh
Rahul Kuver
George N. Ioannou
Watcharin Loilome
Nisana Namwat
Vajarabhongsa Bhudhisawasdi
Ake Pugkhem
Chawalit Pairojkul
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 77.0-82.0
8 0 0 0 0 0 8
24. Identification of pathogenic cholesterol oxidation products in hepatic tissue and bile of cholangiocarcinoma patients A. Jusakul
W. G. Haigh
C. Savard
W. Loilome
N. Namwat
N. Khuntikeo
C. Pairojkul
S. Pinlaor
R. Kuver
P. Yongvanit
2012 FEBS JOURNAL
(279.0), pp. 216.0-216.0
0 0 0 0 0 0 0
25. Impaired Antioxidant Enzyme Activity and Increased DNA Repair Enzyme Expression in Hamster Liver Tissues Related to Cholangiocarcinoma Development Watcharin Loilome
Sasithorn Kadsanit
Nisana Namwat
Anchalee Techasen
Anucha Puapairoj
Ananya Dechakhamphu
Chadamas Pinitsoontorn
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 59.0-64.0
3 0 0 0 0 0 3
26. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen Puangrat Yongvanit
Raynoo Thanan
Somchai Pinlaor
Paiboon Sithithaworn
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Somkid Dechakhamphu
2012 PARASITOLOGY RESEARCH
5.0 (110.0), pp. 1969.0-1977.0
16 0 0 0 0 0 16
27. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes Apinya Jusakul
Watcharin Loilome
Nisana Namwat
W. Geoffrey Haigh
Rahul Kuver
Somkid Dechakhamphu
Pradit Sukontawarin
Somchai Pinlaor
Sum P. Lee
Puangrat Yongvanit
2012 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
1-2 (731.0), pp. 48.0-57.0
34 0 0 0 0 0 34
28. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Kunyarat Duenngai
Ubon Cha'on
Raynoo Thanan
Paiboon Sithithaworn
Masanao Miwa
Puangrat Yongvanit
2012 PARASITOLOGY INTERNATIONAL
1.0 (61.0), pp. 140.0-144.0
12 0 0 0 0 0 12
29. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma Sirintip Boonjaraspinyo
Zhiliang Wu
Thidarut Boonmars
Sasithorn Kaewkes
Watchalin Loilome
Paiboon Sithithaworn
Isao Nagano
Yuzo Takahashi
Puangrat Yongvanit
Vajarabhongsa Bhudhisawasdi
2012 PARASITOLOGY INTERNATIONAL
1.0 (61.0), pp. 145.0-150.0
24 0 0 0 0 0 24
30. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma Sirintip Boonjaraspinyo
Thidarut Boonmars
Zhiliang Wu
Watcharin Loilome
Paiboon Sithithaworn
Isao Nagano
Somchai Pinlaor
Puangrat Yongvanit
Phuangphaka Sadee Nielsen
Chawalit Pairojkul
Narong Khuntikeo
2012 TUMOR BIOLOGY
5.0 (33.0), pp. 1785.0-1802.0
38 0 0 0 0 0 38
31. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group Watcharin Loilome
Sasithorn Yooyuen
Nisana Namwat
Paiboon Sithithaworn
Anucha Puapairoj
Junko Kano
Masayuki Noguchi
Masanao Miwa
Puangrat Yongvanit
2012 TUMOR BIOLOGY
6.0 (33.0), pp. 2289.0-2298.0
10 0 0 0 0 0 10
32. Suppression of PRKAR1A Expression Enhances Antiproliferative and Apoptotic Effects of Protein Kinase Inhibitors and Chemotherapeutic Drugs on Cholangiocarcinoma Cells Watcharin Loilome
Sirinun Juntana
Chadamas Pinitsoontorn
Nisana Namwat
Wichittra Tassaneeyakul
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 143.0-147.0
3 0 0 0 0 0 3
33. Tumor Necrosis Factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma A. Techasen
N. Namwat
W. Loilome
2012 FEBS JOURNAL
(279.0), pp. 169.0-170.0
0 0 0 0 0 0 0
34. Tumor necrosis factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Pornpan Bungkanjana
Narong Khuntikeo
Anucha Puapairoj
Patcharee Jearanaikoon
Hideyuki Saya
Puangrat Yongvanit
2012 MEDICAL ONCOLOGY
5.0 (29.0), pp. 3083.0-3091.0
74 0 0 0 0 0 74
35. Anti-apoptotic phenotypes of cholestan-3 beta,5 alpha,6 beta-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma Apinya Jusakul
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Rahul Kuver
George N. Ioannou
Christopher Savard
W. Geoffrey Haigh
Puangrat Yongvanit
2013 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
(138.0), pp. 368.0-375.0
14 0 0 0 0 0 14
36. Immunosuppressive Prednisolone Enhances Early Cholangiocarcinoma in Syrian Hamsters with Liver Fluke Infection and Administration of N-nitrosodimethylamine Amornrat Juasook
Thidarut Boonmars
Zhiliang Wu
Watcharin Loilome
Kulathida Veteewuthacharn
Nissana Namwat
Pakkayanee Sudsarn
Orasa Wonkchalee
Pranee Sriraj
Ratchadawan Aukkanimart
2013 PATHOLOGY & ONCOLOGY RESEARCH
1.0 (19.0), pp. 55.0-62.0
11 0 0 0 0 0 11
37. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy Supak Yothaisong
Hasaya Dokduang
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Vajarabhongsa Bhudhisawasdi
Anucha Puapairoj
Gregory J. Riggins
Watcharin Loilome
2013 TUMOR BIOLOGY
6.0 (34.0), pp. 3637.0-3648.0
73 0 0 0 0 0 73
38. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis P. Chusorn
N. Namwat
W. Loilome
A. Techasen
C. Pairojkul
N. Khuntikeo
A. Dechakhamphu
C. Talabnin
W. Chan-On
C. K. Ong
B. T. Teh
P. Yongvanit
2013 TUMOR BIOLOGY
3.0 (34.0), pp. 1579.0-1588.0
65 0 0 0 0 0 65
39. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma Wassana Jamnongkan
Anchalee Techasen
Raynoo Thanan
Kunyarat Duenngai
Paiboon Sithithaworn
Eimorn Mairiang
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Puangrat Yongvanit
2013 TUMOR BIOLOGY
2.0 (34.0), pp. 695.0-704.0
23 0 0 0 0 0 23
40. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment Hasaya Dokduang
Sirinun Juntana
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Gregory J. Riggins
Watcharin Loilome
2013 TUMOR BIOLOGY
6.0 (34.0), pp. 3519.0-3528.0
36 0 0 0 0 0 36
41. The expression of PGE2 biosynthesis-related enzymes and PGE2 receptors in cholangiocarcinoma Jurairat Jongthawin
Anchalee Techasen
Puangrat Yongvanit
Watcharin Loilome
Chavalit Pairojkul
Narong Khuntikeo
Nisana Namwat
2013 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(28.0), pp. 425.0-425.0
0 0 0 0 0 0 0
42. Activated macrophages promote Wnt/beta-catenin signaling in cholangiocarcinoma cells Watcharin Loilome
Pornpan Bungkanjana
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Anucha Puapairoj
Narong Khuntikeo
Gregory J. Riggins
2014 TUMOR BIOLOGY
6.0 (35.0), pp. 5357.0-5367.0
60 0 0 0 0 0 60
43. Association of CYP39A1, RUNX2 and Oxidized Alpha-1 Antitrypsin Expression in Relation to Cholangiocarcinoma Progression Chakkaphan Khenjanta
Raynoo Thanan
Apinya Jusakul
Anchalee Techasen
Wassana Jamnongkan
Nisana Namwat
Watcharin Loilome
Chawalit Pairojkul
Puangrat Yongvanit
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
23.0 (15.0), pp. 10187.0-10192.0
12 0 0 0 0 0 12
44. BMP-7 blocks the effects of TGF-beta-induced EMT in cholangiocarcinoma Kassaporn Duangkumpha
Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Raynoo Thanan
Narong Khuntikeo
Puangrat Yongvanit
2014 TUMOR BIOLOGY
10.0 (35.0), pp. 9667.0-9676.0
49 0 0 0 0 0 49
45. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator Runglawan Silakit
Watcharin Loilome
Puangrat Yongvanit
Porncheera Chusorn
Anchalee Techasen
Thidarut Boonmars
Narong Khuntikeo
Nittaya Chamadol
Chawalit Pairojkul
Nisana Namwat
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
12.0 (21.0), pp. 864.0-872.0
66 0 0 0 0 0 66
46. High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis Suyanee Thongchot
Puangrat Yongvanit
Watcharin Loilome
Wanchana Seubwai
Kutcharin Phunicom
Wichittra Tassaneeyakul
Chawalit Pairojkul
Wisuttiphong Promkotra
Anchalee Techasen
Nisana Namwat
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
14.0 (15.0), pp. 5873.0-5878.0
37 0 0 0 0 0 37
47. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients Nittaya Chamadol
Chawalit Pairojkul
Narong Khuntikeo
Vallop Laopaiboon
Watcharin Loilome
Paiboon Sithithaworn
Paungrat Yongvanit
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
5.0 (21.0), pp. 316.0-322.0
57 0 0 0 0 0 57
48. Increased EphB2 expression predicts cholangiocarcinoma metastasis Walaiporn Khansaard
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Anucha Puapairoj
Watcharin Loilome
2014 TUMOR BIOLOGY
10.0 (35.0), pp. 10031.0-10041.0
26 0 0 0 0 0 26
49. Inhibitory effect of xanthohumol on STAT3 activation and cholangiocarcinoma development H. Dokduang
W. Loilome
N. Namwat
C. Pairojkul
M. Sakurai-Yageta
Y. Murakami
P. Yongvanit
2014 EUROPEAN JOURNAL OF CANCER
(50.0), pp. S197-S197
0 0 0 0 0 0 0
50. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anucha Puapairoj
Patcharee Jearanaikoon
Hideyuki Saya
Puangrat Yongvanit
2014 TUMOR BIOLOGY
9.0 (35.0), pp. 8645.0-8652.0
43 0 0 0 0 0 43
51. Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma Zhiliang Wu
Thidarut Boonmars
Isao Nagano
Watcharin Loilome
Puangrat Yongvanit
Narong Khuntikeo
Phuangphaka Sadee Nielsen
Chawalit Paorojkul
Yuzo Takahashi
Yoichi Maekawa
2014 TUMOR BIOLOGY
3.0 (35.0), pp. 1985.0-1995.0
2 0 0 0 0 0 2
52. Opisthorchis viverrini Infection Activates the PI3K/AKT/PTEN and Wnt/beta-catenin Signaling Pathways in a Cholangiocarcinogenesis Model Supak Yothaisong
Malinee Thanee
Nisana Namwat
Puangrat Yongvanit
Thidarut Boonmars
Anucha Puapairoj
Watcharin Loilome
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
23.0 (15.0), pp. 10463.0-10468.0
25 0 0 0 0 0 25
53. PGE(2) signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jurairat Jongthawin
Porncheera Chusorn
Anchalee Techasen
Watcharin Loilome
Thidarut Boonmars
Raynoo Thanan
Anucha Puapairoj
Narong Khuntikeo
Wichittra Tassaneeyakul
Puangrat Yongvanit
Nisana Namwat
2014 TUMOR BIOLOGY
8.0 (35.0), pp. 8051.0-8064.0
10 0 0 0 0 0 10
54. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma Puangrat Yongvanit
Somchai Pinlaor
Watcharin Loilome
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
5.0 (21.0), pp. 309.0-315.0
33 0 0 0 0 0 33
55. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression Hasaya Dokduang
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Chawalit Pairojkul
Yoshinori Murakami
Watcharin Loilome
Puangrat Yongvanit
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
10.0 (21.0), pp. 767.0-776.0
52 0 0 0 0 0 52
56. Survey of activated kinase proteins reveals PI3K/Akt and Wnt/beta-catenin signaling pathways as potential targets for cholangiocarcinoma treatment W. Loilome
H. Dokduang
S. Yothaisong
P. Bungkanjana
S. Juntana
A. Techasen
N. Namwat
P. Yongvanit
N. Khuntikeo
A. Puapairoj
2014 EUROPEAN JOURNAL OF CANCER
(50.0), pp. S210-S210
0 0 0 0 0 0 0
57. TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma P. Chusorn
N. Namwat
W. Loilome
A. Techasen
C. Pairojkul
N. Khuntikeo
B. Tean Teh
I. Lee
P. Yongvanit
2014 EUROPEAN JOURNAL OF CANCER
(50.0), pp. S63-S64
0 0 0 0 0 0 0
58. Tumor necrosis factor-alpha modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Kassaporn Duangkumpha
Anucha Puapairoj
Hideyuki Saya
Puangrat Yongvanit
2014 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
9.0 (21.0), pp. 703.0-711.0
44 0 0 0 0 0 44
59. Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine Chanika Worasith
Christine Kamamia
Anna Yakovleva
Kunyarat Duenngai
Chompunoot Wangboon
Jiraporn Sithithaworn
Nattaya Watwiengkam
Nisana Namwat
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Alex Loukas
Paiboon Sithithaworn
Jeffrey M. Bethony
2015 PLoS Neglected Tropical Diseases
10.0 (9.0), pp.
35 2 0 0 0 0 37
60. Cohort profile: cholangiocarcinoma screening and care program (CASCAP) Narong Khuntikeo
Nittaya Chamadol
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Paiboon Sithithaworn
Ross H. Andrews
Trevor N. Petney
Supannee Promthet
Kavin Thinkhamrop
Chaiwat Tawarungruang
Bandit Thinkhamrop
2015 BMC CANCER
(15.0), pp.
67 2 0 0 0 0 69
61. Oxidative stress induced LAT1/CD98 expression via PI3K/AKT signaling pathway in cholangiocarcinoma: a potential therapeutic target Supak Yothaisong
Watcharin Loilome
Promsuk Jutabha
Hasaya Dokduang
Hitoshi Endou
Naohiko Anzai
2015 JOURNAL OF PHARMACOLOGICAL SCIENCES
3.0 (128.0), pp. S102-S102
0 0 0 0 0 0 0
62. A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand Narong Khuntikeo
Watcharin Loilome
Bandit Thinkhamrop
Nittaya Chamadol
Puangrat Yongvanit
2016 PLOS NEGLECTED TROPICAL DISEASES
1.0 (10.0), pp.
43 0 0 0 0 0 43
63. CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Eiji Sugihara
Shogo Okazaki
Shinya Abe
Shiho Ueda
Takashi Masuko
Nisana Namwat
Narong Khuntikeo
Attapol Titapun
Chawalit Pairojkul
Hideyuki Saya
Puangrat Yongvanit
2016 CANCER SCIENCE
7.0 (107.0), pp. 991.0-1000.0
36 0 0 0 0 0 36
64. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma Pakkayanee Sudsarn
Thidarut Boonmars
Wipaporn Ruangjirachuporn
Nisana Namwat
Watcharin Loilome
Pranee Sriraj
Ratchadawan Aukkanimart
Wonkchalee Nadchanan
Songsri Jiraporn
2016 PATHOLOGY & ONCOLOGY RESEARCH
1.0 (22.0), pp. 57.0-65.0
4 0 0 0 0 0 4
65. Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma Xurui Dai
Suyanee Thongchot
Hasaya Dokduang
Watcharin Loilome
Narong Khuntikeo
Attapol Titapun
Piti Ungarreevittaya
Puangrat Yongvanit
Anchalee Techasen
Nisana Namwat
2016 ANTICANCER RESEARCH
11.0 (36.0), pp. 5981.0-5988.0
12 0 0 0 0 0 12
66. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells Hasaya Dokduang
Puangrat Yongvanit
Nisana Namwat
Chawalit Pairojkul
Sakkarn Sangkhamanon
Mika Sakurai Yageta
Yoshinori Murakami
Watcharin Loilome
2016 ONCOLOGY REPORTS
4.0 (35.0), pp. 2065.0-2072.0
24 0 0 0 0 0 24
67. Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma Watcharin Loilome
Sasithorn Kadsanit
Kanha Muisook
Puangrat Yongvanit
Nisana Namwat
Anchalee Techasen
Anucha Puapairoj
Narong Khuntikeo
Pichai Phonjit
2017 ONCOLOGY LETTERS
2.0 (13.0), pp. 639.0-646.0
0 0 0 0 0 0 0
68. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance Supak Yothaisong
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Anucha Puapairoj
Promsuk Jutabha
Naohiko Anzai
Wichittra Tassaneeyakul
Panot Tangsucharit
Watcharin Loilome
2017 PARASITOLOGY INTERNATIONAL
4.0 (66.0), pp. 471.0-478.0
6 0 0 0 0 0 6
69. Inhibition of L-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment Supak Yothaisong
Hasaya Dokduang
Naohiko Anzai
Keitaro Hayashi
Nisana Namwat
Puangrat Yongvanit
Sakkarn Sangkhamanon
Promsuk Jutabha
Hitoshi Endou
Watcharin Loilome
2017 TUMOR BIOLOGY
3.0 (39.0), pp.
19 0 0 0 0 0 19
70. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process Sureerat Padthaisong
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Aekkaphod Liwatthakun
Khittisak Hankla
Sakkarn Sangkhamanon
Watcharin Loilome
2017 ANTICANCER RESEARCH
7.0 (37.0), pp. 3591.0-3597.0
14 0 0 0 0 0 14
71. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem Thomas Hughes
Thomas O'Connor
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Ross H. Andrews-
Narong Khuntikeo
Puangrat Yongvanit
Paiboon Sithithaworn
Simon D. Taylor-Robinson
2017 INTERNATIONAL JOURNAL OF GENERAL MEDICINE
(10.0), pp. 227.0-237.0
31 0 0 0 0 0 31
72. Protein Kinases as Targets for Opisthorchis viverrini- Associated Cholangiocarcinoma Therapy Watcharin Loilome
Hasaya Dokduang
2017 CURRENT PHARMACEUTICAL DESIGN
29.0 (23.0), pp. 4281.0-4289.0
4 0 0 0 0 0 4
73. Teleconsultation ultrasonography: a new weapon to combat cholangiocarcinoma Nittaya Chamado
Vallop Laopaiboon
Jiraporn Srinakarin
Watcharin Loilome
Puangrat Yongvanit
Bandit Thinkhamrop
Narong Khuntikeo
2017 ESMO OPEN
3.0 (2.0), pp.
5 0 0 0 0 0 5
74. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance Manida Suksawat
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Supinda Koonmee
Watcharin Loilome
2017 PARASITOLOGY INTERNATIONAL
4.0 (66.0), pp. 486.0-493.0
10 0 0 0 0 0 10
75. Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis Nattaporn Phanthaphol
Anchalee Techasen
Watcharin Loilome
Suyanee Thongchot
Raynoo Thanan
Sakkarn Sungkhamanon
Narong Khuntikeo
Puangrat Yongvanit
Nisana Namwat
2017 ONCOLOGY LETTERS
5.0 (14.0), pp. 5973.0-5979.0
4 0 0 0 0 0 4
76. Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool Wassana Jamnongkan
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
Piyapharom Intarawichian
Attapol Titapun
Puangrat Yongvanit
2017 TUMOR BIOLOGY
7.0 (39.0), pp.
12 0 0 0 0 0 12
77. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group Runglawan Silakit
Watcharin Loilome
Puangrat Yongvanit
Suyanee Thongchot
Paiboon Sithithaworn
Thidarut Boonmars
Supinda Koonmee
Attapol Titapun
Narong Khuntikeo
Nittaya Chamadol
Anchalee Techasen
Nisana Namwat
2017 PARASITOLOGY INTERNATIONAL
4.0 (66.0), pp. 479.0-485.0
26 0 0 0 0 0 26
78. Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Rayno Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
Anchalee Techasen
2018 PEERJ
(6.0), pp.
4 0 0 0 0 0 4
79. CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment Malinee Thanee
Watcharin Loilome
Anchalee Techasen
Nisana Namwat
Attapon Titapun
Narong Khuntikeo
Shogo Okazaki
Eiji Sugihara
Hideyuki Saya
Puangrat Yongvanit
2018 CANCER SCIENCE
(109.0), pp. 37.0-37.0
0 0 0 0 0 0 0
80. Cellular senescence and inhibitory effects of PRIMA-1MET in cholangiocarcinoma Chayanit Piyawajanusorn
Watcharin Loilome
Yingpinyapat Kittirat
Suyanee Thongchot
Nisana Namwat
2018 CANCER SCIENCE
(109.0), pp. 1382.0-1382.0
0 0 0 0 0 0 0
81. Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia Narong Khuntikeo
Attapol Titapun
Watcharin Loilome
Puangrat Yongvanit
Bandit Thinkhamrop
Nittaya Chamadol
Thidarat Boonmars
Teerachai Nethanomsak
Ross H. Andrews
Trevor N. Petney
Paiboon Sithithaworn
2018 FRONTIERS IN MEDICINE
(5.0), pp.
10 0 0 0 0 0 10
82. Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis Chatanun Eamudomkarn
Paiboon Sithithaworn
Christine Kamamia
Anna Yakovleva
Jiraporn Sithithaworn
Sasithorn Kaewkes
Anchalee Techasen
Watcharin Loilome
Puangrat Yongvanit
Chompunoot Wangboon
Prasert Saichua
Makoto Itoh
Jeffrey M. Bethony
2018 PLOS ONE
7.0 (13.0), pp.
6 0 0 0 0 0 6
83. Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway Suyanee Thongchot
Chiara Vidoni
Alessandra Ferraresi
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
Ciro Isidoro
2018 MOLECULAR CARCINOGENESIS
12.0 (57.0), pp. 1735.0-1750.0
9 0 0 0 0 0 9
84. Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis Anchalee Techasen
Wassana Jamnongkan
Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
Raynoo Thanan
Phongsaran Kimawaha
Tidarat Boonmars
Runglawan Silakit
Nisana Namwat
2018 CANCER SCIENCE
(109.0), pp. 721.0-721.0
0 0 0 0 0 0 0
85. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis Chompunoot Wangboon
Puangrat Yongvanit
Watcharin Loilome
Raynoo Thanan
Chanika Worasith
Chatanun Eamudomkarn
Nittaya Chamadol
Eimorn Mairiang
Jiraporn Sithithaworn
Prasert Saichua
Banchob Sripa
Narong Khuntikeo
Jeffrey M. Bethony
Paiboon Sithithaworn
2018 AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
6.0 (98.0), pp. 1763.0-1769.0
9 0 0 0 0 0 9
86. Increasing of 5-lipoxygenase expression associated with cholangiocarcinoma development Sasikamon Korphai
Anchalee Techasen
Nisana Namwat
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 194.0-194.0
0 0 0 0 0 0 0
87. Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy Manida Suksawat
Anchalee Techasen
Nisana Namwat
Thianrut Boonsong
Attapol Titapun
Piti Ungarreevittaya
Puangrat Yongvanit
Watcharin Loilome
2018 FEBS OPEN BIO
4.0 (8.0), pp. 513.0-522.0
3 0 0 0 0 0 3
88. Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth Hasaya Dokduang
Manida Suksawat
Sureerat Padthaisong
Wassana Jamnongkarn
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Narong Khuntikeao
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 746.0-746.0
0 0 0 0 0 0 0
89. Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapol Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018 ONCOLOGY LETTERS
2.0 (16.0), pp. 1627.0-1633.0
3 0 0 0 0 0 3
90. Oxidative stress down-regulates Early B cell factor 1 resulting in cholangiocarcinoma genesis Napat Armartmuntree
Mariko Murata
Anchalee Techasen
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Chadamas Sakonsinsiri
Somchai Pinlaor
Raynoo Thanan
2018 CANCER SCIENCE
(109.0), pp. 1286.0-1286.0
0 0 0 0 0 0 0
91. Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth Sureerat Padthaisong
Hasaya Dokduang
Supak Yothaisong
Anchalee Techasen
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Attapon Titapun
Sakkarn Sangkhamanon
Watcharin Loilome
2018 CANCER SCIENCE
(109.0), pp. 745.0-745.0
0 0 0 0 0 0 0
92. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells Runglawan Silakit
Yingpinyapat Kitirat
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Piti Ungarreevittaya
Narong Khuntikeo
Puangrat Yongvanit
Ji Hye Yang
Nam Hee Kim
Jong In Yook
Nisana Namwat
2018 PLOS ONE
6.0 (13.0), pp.
4 0 0 0 0 0 4
93. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway Minerva Daya
Watcharin Loilome
Anchalee Techasen
Malinee Thanee
Prakasit Sa-Ngiamwibool
Attapol Titapun
Puangrat Yongvanit
Nisana Namwat
2018 ONCOTARGETS AND THERAPY
(11.0), pp. 395.0-408.0
11 0 0 0 0 0 11
94. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis Napat Armartmuntree
Mariko Murata
Anchalee Techasen
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Chawalit Pairojkul
Chadamas Sakonsinsiri
Somchai Pinlaor
Raynoo Thanan
2018 REDOX BIOLOGY
(14.0), pp. 637.0-644.0
53 0 0 0 0 0 53
95. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells Suyanee Thongchot
Alessandra Ferraresi
Chiara Vidoni
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
Ciro Isidoro
2018 CANCER LETTERS
(430.0), pp. 160.0-171.0
14 0 0 0 0 0 14
96. Resveratrol interrupts the pro -invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells (vol 430C, pg 160, 2018) Suyanee Thongchot
Alessandra Ferraresi
Chiara Vidoni
Watcharin Loilome
Puangrat Yongvanit
Nisana Namwat
Ciro Isidoro
2018 CANCER LETTERS
(434.0), pp. 206.0-207.0
0 0 0 0 0 0 0
97. Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine Yingpinyapat Kittirat
Anchalee Techasen
Suyanee Thongchot
Watcharin Loilome
Raynoo Thanan
Puangrat Yongvanit
Sakkarn Sungkhamanon
Attapol Titapun
Narong Khuntikeo
Nisana Namwat
2018 ONCOLOGY LETTERS
1.0 (15.0), pp. 347.0-353.0
8 0 0 0 0 0 8
98. TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma Phongsaran Kimawaha
Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anchalee Techasen
2018 CANCER SCIENCE
(109.0), pp. 956.0-956.0
0 0 0 0 0 0 0
99. The Socioeconomic Burden of Cholangiocarcinoma Associated With Opisthorchis viverrini Sensu Lato Infection in Northeast Thailand: A Preliminary Analysis Narong Khuntikeo
Bandit Thinkhamrop
Kanitta Bundhamcharoen
Ross H. Andrews
Carl Grundy-Warr
Puangrat Yongvanit
Watcharin Loilome
Nittaya Chamadol
Weerachai Kosuwan
Paiboon Sithithaworn
Trevor N. Petney
2018 ASIATIC LIVER FLUKE - FROM BASIC SCIENCE TO PUBLIC HEALTH, PT B
(102.0), pp. 141.0-+
4 0 0 0 0 0 4
100. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway Sasikamon Khophai
Malinee Thanee
Anchalee Techasen
Nisana Namwat
Poramate Klanrit
Attapol Titapun
Apiwat Jarearnrat
Prakasit Sa-Ngiamwibool
Watcharin Loilome
2018 ONCOTARGETS AND THERAPY
(11.0), pp. 7019.0-7029.0
2 0 0 0 0 0 2
101. Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma Munirah Alsaleh
Paiboon Sithithaworn
Narong Khuntikeo
Watcharin Loilome
Puangrat Yongvanit
Nittaya Chamadol
Thomas Hughes
Thomas O'Connor
Ross H. Andrews
Elaine Holmes
Simon D. Taylor-Robinson
2019 JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY
6.0 (9.0), pp. 657.0-675.0
0 0 0 0 0 0 0
102. Cholangiocarcinoma: a guide for the nonspecialist Munirah Alsaleh
Zoe Leftley
Thomas A. Barbera
Paiboon Sithithaworn
Narong Khuntikeo
Watcharin Loilome
Puangrat Yongvanit
I. Jane Cox
Nittaya Chamodol
Richard R. A. Syms
Ross H. Andrews
Simon D. Taylor-Robinson
2019 INTERNATIONAL JOURNAL OF GENERAL MEDICINE
(12.0), pp. 13.0-23.0
4 0 0 0 0 0 4
103. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand Chanika Worasith
Chompunoot Wangboon
Kunyarat Duenngai
Nadda Kiatsopit
Kulthida Kopolrat
Anchalee Techasen
Jiraporn Sithithaworn
Narong Khuntikeo
Watcharin Loilome
Nisana Namwat
Puangrat Yongvanit
Elizabeth J. Carlton
Paiboon Sithithaworn
2019 PLOS NEGLECTED TROPICAL DISEASES
2.0 (13.0), pp.
0 0 0 0 0 0 0
104. Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis Kassaporn Duangkumpha
Thomas Stoll
Jutarop Phetcharaburanin
Puangrat Yongvanit
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Nittaya Chamadol
Sittiruk Roytrakul
Jason Mulvenna
Ahmed Mohamed
Alok K. Shah
Michelle M. Hill
Watcharin Loilome
2019 JOURNAL OF PROTEOME RESEARCH
9.0 (18.0), pp. 3305.0-3316.0
1 0 0 0 0 0 1
105. Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma Wassana Jamnongkan
Carlito B. Lebrilla
Mariana Barboza
Anchalee Techasen
Watcharin Loilome
Paiboon Sithithaworn
Narong Khuntikeo
Chawalit Pairojkul
Nittaya Chamadol
Raynoo Thanan
Puangrat Yongvanit
2019 BIOMOLECULES
10.0 (9.0), pp.
1 0 0 0 0 0 1
106. Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines Bundit Promraksa
Jutarop Phetcharaburanin
Nisana Namwat
Anchalee Techasen
Patcharee Boonsiri
Watcharin Loilome
2019 PLOS ONE
5.0 (14.0), pp.
0 0 0 0 0 0 0
107. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG Chompunoot Wangboon
Chanika Worasith
Raynoo Thanan
Chatanun Eamudomkarn
Anchalee Techasen
Jiraporn Sithithaworn
Watcharin Loilome
Nittaya Chamadol
Somchai Pinlaor
Amonrat Jumnainsong
Puangrat Yongvanit
Narong Khuntikeo
Jeffrey M. Bethony
Paiboon Sithithaworn
2019 ACTA TROPICA
(189.0), pp. 124.0-128.0
2 0 0 0 0 0 2
108. Mass Spectrometry: A Guide for the Clinician Munirah Alsaleh
Thomas A. Barbera
Ross H. Andrews
Paiboon Sithithaworn
Narong Khuntikeo
Watcharin Loilome
Puangrat Yongvanit
Isobel J. Cox
Richard R. A. Syms
Elaine Holmes
Simon D. Taylor-Robinson
2019 JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY
5.0 (9.0), pp. 597.0-606.0
0 0 0 0 0 0 0
109. PRIMA-1(MET) Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells Chayanit Piyawajanusorn
Yingpinyapat Kittirat
Prakasit Sa-Ngiamwibool
Attapol Titapun
Watcharin Loilome
Nisana Namwat
2019 CANCER GENOMICS & PROTEOMICS
6.0 (16.0), pp. 543.0-552.0
0 0 0 0 0 0 0
110. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis Kassaporn Duangkumpha
Thomas Stoll
Jutarop Phetcharaburanin
Puangrat Yongvanit
Raynoo Thanan
Anchalee Techasen
Nisana Namwat
Narong Khuntikeo
Nittaya Chamadol
Sittiruk Roytrakul
Jason Mulvenna
Ahmed Mohamed
Alok K. Shah
Michelle M. Hill
Watcharin Loilome
2019 PLOS ONE
8.0 (14.0), pp.
0 0 0 0 0 0 0
111. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma Sureerat Padthaisong
Malinee Thanee
Nisana Namwat
Jutarop Phetcharaburanin
Poramate Klanrit
Narong Khuntikeo
Attapol Titapun
Watcharin Loilome
2020 BMC CANCER
1.0 (20.0), pp.
0 0 0 0 0 0 0
112. AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine Wichit Taron
Wassana Jamnongkan
Anchalee Techasen
Jutarop Phetcharaburanin
Nisana Namwat
Paiboon Sithithaworn
Narong Khuntikeo
Siriboon Mukdasai
Somphou Sayasone
Watcharin Loilome
Wittaya Ngeontae
2020 TALANTA
(209.0), pp.
0 0 0 0 0 0 0
113. Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort Munirah Alsaleh
Zoe Leftley
Thomas A. Barbera
Larry K. Koomson
Abigail Zabron
Mary M. E. Crossey
Helen L. Reeves
Matthew Cramp
Stephen Ryder
Shaun Greer
Martin Prince
Paiboon Sithithaworn
Mohamed Shariff
Narong Khuntikeo
Watcharin Loilome
Puangrat Yongvanit
Yi-Liang Shen
I. Jane Cox
Roger Williams
Christopher A. Wadsworth
Elaine Holmes
Kathryn Nash
Simon D. Taylor-Robinson
2020 JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY
1.0 (10.0), pp. 17.0-29.0
0 0 0 0 0 0 0
114. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma Sureerat Padthaisong
Malinee Thanee
Nisana Namwat
Jutarop Phetcharaburanin
Poramate Klanrit
Narong Khuntikeo
Attapol Titapun
Sakkarn Sungkhamanon
Hideyuki Saya
Watcharin Loilome
2020 JOURNAL OF TRANSLATIONAL MEDICINE
1.0 (18.0), pp.
0 0 0 0 0 0 0

Title Authors Year Journal title
1. Expression and Function of Candidate Genes Involved in Cholangiocarcinama Watcharin Loilome
Puangrat Yongvanit
2005 Srinagarind Medical Journal
(20 No 3), pp. 159-163
2. Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines Nisana Namwat
Banchob Sripa
Watcharin Loilome
Vajarabhongsa Bhudisawadi
Wichittra Tassaneeyakul
2007 Srinagarind Medical Journal
(22 No 3), pp. 230-234
3. Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation Hasaya Dokduang
Nisana Namwat
Apinya Jusakul
Vajarabhongsa Bhudisawadi
Watcharin Loilome
Puangrat Yongvanit
Banchob Sripa
Wichittra Tassaneeyakul
2010 Srinagarind Medical Journal
(25 No 1), pp. 2-5
4. Adverse Effects Caused by Adaptive Imbalance to Genotoxic Stress after Infection and Inflammation Sasithorn Kadsanit
Chadamas Pinitsoontorn
Watcharin Loilome
Puangrat Yongvanit
2011 Srinagarind Medical Journal
(26 No 2), pp. 127-135
5. PI3K/Akt Signaling Pathway in Normal and Malignant Cells Supak Yothaisong
Watcharin Loilome
2012 Srinagarind Medical Journal
(27 No 1), pp. 66-76
6. Tumor Microenvironment and its Functions Malinee Thanee
Puangrat Yongvanit
Watcharin Loilome
2012 Srinagarind Medical Journal
(27 No 4), pp. 424-432
7. Molecular Carcinogenesis of Cholangiocarcinoma II: Associated Genes in the Genesis of Cholangiocarcinoma Nisana Namwat
Watcharin Loilome
Puangrat Yongvanit
Thailand Khon Kaen University
2012 Srinagarind Medical Journal
(27), pp. 364-370
8. Inhibitory Effects of Xanthohumol on STAT3 Activation and Cancer Development in Cholangiocarcinoma Xenograft Model Hasaya Dokduang
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Chawalit Pairojkul
Narong Khuntikeo
Yoshinori Murakami
Puangrat Yongvanit
2013 Srinagarind Medical Journal
(28 No 4), pp. 195
9. Expression of 14-3-3 Sigma Protein in Cholangiocarcinoma Progression Yingpinyapat Kittirat
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014 Srinagarind Medical Journal
(29 No 4), pp. 133-135
10. Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma Xurui Dai
Suyanee Thongchot
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014 Srinagarind Medical Journal
(29 No 4), pp. 138-140
11. Gene Silencing of Translationally Controlled Tumor Protein (TCTP) Nattaporn Phanthaphol
Watcharin Loilome
Anchalee Techasen
Puangrat Yongvanit
Nisana Namwat
2014 Srinagarind Medical Journal
(29 No 4), pp. 136-137

Title Authors NRIIS type Year NRIIS Scholarship

0.05904340744018555